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Abstract 
The role of persistent organic pollutants (POPs) in marine wildlife health is an issue of continuous 
interest worldwide. Dugongs and marine turtles, two iconic species contributing to the unique 
diversity of the Australian coastal environment, are both experiencing multiple threats of natural 
and anthropogenic origins. These animals typically feed in coastal areas where release of POPs 
occurs from urban, agricultural and industrial activities. Given the high fat content of dugongs and a 
long life span for both species, these animals can accumulate relatively high amounts of POPs. 
While certain POP groups (such as polychlorinated dibenzo-p-dioxins/furans, PCDD/Fs and 
polychlorinated biphenyls, PCBs) in these animals can be present at elevated levels where adverse 
effects may occur, dugongs and turtles are in reality exposed to an even broader spectrum of 
chemicals, and the combined effect of such complex, unresolved mixtures remains largely unknown.  
 
Investigations on mixtures in wildlife are often hindered by conventional exhaustive solvent 
extraction methods, which require select solvent use and extensive clean-up to remove the complex 
matrices and therefore can only cover a limited spectrum of chemicals. Another challenge lies in the 
choice of representative biological endpoints to explore the toxicological relevance of accumulated 
chemical burdens and quantitatively link chemical exposure and mixture effect.  
 
In light of these limitations, this thesis aimed to deliver a methodological framework to link 
chemical exposure to mixture effects for typical biological sample types. More specifically, the goal 
was to validate and apply polymer-based passive sampling strategies suitable for dosing into in vitro 
bioassays with endpoints of relevance to both chemical exposure and wildlife health. Lipid-rich 
tissue (blubber) of dugongs and blood of green turtles were used for the method development but 
the methods should be readily transferable to other species. 
 
A simple passive sampling technique using polydimethylsiloxane (PDMS) polymer was validated 
for quantitative extraction of an entire range of neutral organic chemicals from lipid-rich tissue or 
blood based on equilibrium partitioning between PDMS and major sorptive phases therein (e.g., 
lipid and proteins). For lipid-rich tissue, chemicals reached equilibrium between PDMS and lipid 
within 24 h. Governed by a generally constant lipid-PDMS partition coefficient (Klip-PDMS) of 30 
gPDMS glip-1 (95% CI: 18-57 Lblood kgPDMS-1), neutral organic chemicals across a wide hydrophobicity 
range diffuse proportionally from lipid into PDMS. For blood, a quantitative PDMS-blood 
partitioning system was designed to enrich neutral organic chemicals into PDMS from blood. The 
sampling kinetics of PCDDs into PDMS was reasonably fast, with an estimated equilibration time 
of <96 h. The measured PDMS-blood partition coefficient (KPDMS-blood) for a range of PCDDs, 
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PCBs and PBDEs was generally constant with a geometric mean of 14 Lblood kgPDMS-1 (95% CI: 8.4-
29 Lblood kgPDMS-1). The constant Klip-PDMS or KPDMS-blood allows the conversion of effect-based 
chemical burden in PDMS detected by bioassays into lipid-normalized chemical burden in blubber 
or blood samples.  
 
The validated passive sampling techniques were applied to 34 blubber samples of dugongs stranded 
along the Queensland coast over the last decade and 15 blood samples of green turtles collected 
from Gladstone, Queensland. Passive sampling extracts of dugong blubber were applied to a range 
of reporter gene assays indicative of cellular pathways mediated by transcriptional regulators, 
ranging from induction of metabolism to adaptive stress response. Induction of arylhydrocarbon 
receptor (AhR) and Nrf2-mediated oxidative stress response were the dominant modes of action, 
while p53-mediated DNA damage response and NFκB-mediated response to inflammation were of 
low relevance in both individual chemical profiling and dugong blubber extract screening. A 
quantitative link was found between the potency of AhR active chemicals, such as PCDDs, PCBs 
and polyaromatic hydrocarbons (PAHs), and their respective potency to induce the oxidative stress 
response pathway. While analytically quantified PCDDs could account for the entire AhR-mediated 
activity, less than 5% of the total oxidative stress response could be explained by PCDDs. An 
increase or decrease in oxidative stress response was observed with individual chemicals and 
blubber extracts subject to metabolic activation by rat liver S9 fraction, suggesting the utility of 
incorporating metabolic enzymes into in vitro bioassays. Similar to what was observed with 
dugongs, target chemical analysis of PCDD/Fs, dioxin-like PCBs, polybrominated diphenyl ethers 
(PBDEs) and organochlorine pesticides showed that identified chemicals contributed to the majority 
of the AhR-mediated activity and less than 0.4% of Nrf2-mediated response.  
  
In conclusion, this thesis combined efficient passive sampling techniques to extract chemicals in 
biological samples with in vitro bioanalytical tools for quantitative screening of total toxicologically 
relevant chemical burdens in marine wildlife. These innovative tools will enable high throughput 
screening of biota samples, thus facilitating our future efforts in understanding toxicological 
implications of wildlife exposure to complex mixtures of POPs. The data generated will inform risk 
assessment of chemical mixtures and contribute to mitigation strategies for wildlife conservation. 
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Chapter I. Background and Thesis Scope 
 
As a unique part of the Australian coastal biodiversity, dugongs and marine turtles, particularly 
those free ranging in nearshore habitats, are encountering various environmental threats from 
natural and human influences (reviewed in Chapter II). Among these, a myriad of chemical 
pollutants have the potential to impact turtles’ health in a way that, for instance, suppresses their 
immune function and thus renders them less capable of coping with environmental stressors 
(reviewed in Chapter II). Lack of time- and cost-effective tools has principally limited our 
capability of assessing the entire chemical mixture as a whole (reviewed in Chapter II). In such 
sense, we are still far away from fully understanding the population health implications of 
pollutants, without addressing the combined effect of total pollutant burdens in turtles. 
!
To address these limitations, the overall objective of the research undertaken for this PhD was to 
deliver a methodological framework to link chemical exposure to mixture effects by validating 
passive sampling strategies suitable for dosing into cell-based bioassays (Figure 1). A test battery 
was applied that covered representative endpoints along the cellular toxicity pathway ranging from 
induction of metabolism, adaptive stress response. The outcomes of this thesis are expected to 
considerably aid future research on understanding links of mixture effects to chemical burden and 
possibly adverse health outcomes in dugongs and turtles from Australia. 
 
As illustrated in Figure 1, the specific aims of the research embodied in this thesis included: 
1.! Evaluating the extraction efficiency of passive sampling of bioaccumulative chemicals from 
tissue or blood and testing the compatibility of passive sampling extracts with chemically 
specific cell bioassays; 
2.! Adopting a panel of in vitro bioassays indicative of toxicity pathways including stress 
response pathways (oxidative stress, DNA damage, inflammation) with particular relevance 
to both chemical exposure and health implications in marine wildlife;  
3.! Applying these tools for effect-based screening of chemical pollutants in dugongs and turtles 
and evaluating the quantitative contribution of select POPs to the mixture effects. 
 
Following Chapter II, which discusses the current bioanalytical approaches to assessing mixtures 
of POPs in marine wildlife, Chapter III describes a comprehensive proof-of-concept study on 
linking a polydimethylsiloxane (PDMS) polymer-based passive sampling technique to in vitro 
bioassays for quantitative screening of bioaccumulative chemicals in lipid-rich tissue (i.e., dugong 
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blubber). In a subsequent study (Chapter IV), the PDMS-based passive sampling method was 
coupled with toxicity pathway-based in vitro bioassays to evaluate the toxic potential of mixtures of 
POPs in archived blubber samples of dugongs from the Queensland coast. Building upon the 
PDMS-lipid partitioning model, Chapter V developed a quantitative extraction method for blood 
and applied the method to evaluate the contribution of select POPs to overall toxic potential in 
blood of green turtles collected in response to a mass stranding event in Gladstone, Queensland. 
Chapter VI summarised the key outcomes of the thesis and provided recommendations for future 
research. 
 
 
 
Figure 1. Overall objectives of the thesis. 
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Chapter II. Bioanalytical Approaches to Understanding Toxicological 
Implications of Persistent Organic Pollutants in Marine Wildlife 
 
Reprinted with permission from: Jin, L., Gaus, C., Escher, B.I. 2015. Chapter 2 - Bioanalytical 
approaches to understanding toxicological implications of mixtures of persistent organic pollutants 
in marine wildlife. In: Zeng, E.Y. (Ed.), Comprehensive Analytical Chemistry. Elsevier, pp. 57-84. 
Copyright (2015) Elsevier. 
 
This chapter reviews the methodological and technological advances for assessing persistent 
organic pollutants in marine wildlife and points out the need for a more integrated methodological 
framework for linking chemical exposure and mixture effects. The selectivity of existing extraction 
methods and chemical analysis of predefined target chemicals have limited our capability of 
assessing the entire mixture of POPs as an entity, thus warranting continuous development of 
quantitative, unbiased sampling techniques and non-target chemical analysis. On the other hand, we 
need further mechanistic, quantitative understanding of biological pathways linking chemical 
exposure to adverse health outcomes to design a purpose-tailored test battery of bioassays for the 
comprehensive toxicological profiling of POP mixtures.  
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Chapter III. Applicability of Passive Sampling to Bioanalytical 
Screening of Bioaccumulative Chemicals in Marine Wildlife 
 
Reprinted with permission from: Jin, L., van Mourik, L., Gaus, C. and Escher, B.I. 2013. 
Applicability of passive sampling to bioanalytical screening of bioaccumulative chemicals in 
marine wildlife. Environmental Science & Technology 47, 7982-7988. Copyright (2013) American 
Chemical Society. 
 
This chapter responds to one of the major methodological gaps in current approaches to addressing 
mixture effect in marine wildlife, that is, the lack of methods for efficient, quantitative and 
comprehensive extraction of bioaccumulative chemicals from biological samples to reflect the 
realm of environmental mixtures.  
 
To address the limitations, we provided a proof-of-concept for linking a polymer-based passive 
sampling technique to in vitro bioassays. This allows quantitative extraction and screening of 
chemical mixtures in lipid-rich tissue. The validated method was applied to screen dioxin-like 
activity of native dugong blubber samples where the observed biological effect correlated well with 
instrumental analysis. The successful proof of concept confirms the applicability of using passive 
sampling devices to screen mixtures of bioaccumulative chemicals for other toxicological endpoints 
for a diversity of wildlife.  
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Supporting information 
 
Applicability of passive sampling to bioanalytical screening of 
bioaccumulative chemicals in marine wildlife 
 
Section SI-1: Additional information on linear regression of Klipw and KPDMSw against Kow. 
Literature data of Klipw (reviewed by Endo et al.1) and KPDMSw (reviewed by DiFilippo et al.2 plus 
some recent entries3, 4) were sought for linear regression analyses against Kow. For both regression 
analyses, chemicals with logKow lower than 2 were excluded due to a leveling off effect. If a 
chemical has multiple values for the partition coefficients, a geometric mean was taken. The slope 
of the regression line was fixed at 1 (close to 1 when it was not fixed with similar residual error) 
(Figure SI-1A). As demonstrated by the regression equations, Klipw is in general 1:1 and KPDMSw 1:10 
in relation to hydrophobicity as indicated by octanol-water partition coefficients (Kow) (Figure SI-
1B). The difference in intercept between the two parallel lines represents the theoretical value of 
logKlip-PDMS (1.01, thus Klip-PDMS ~10) (Figure SI-1B).  
 
Figure SI-1: A) logKlipw (blue empty square) and logKPDMSw (black empty diamond) in relation to 
logKow indicative of hydrophobicity; B) Conceptual figure showing the theoretical relationship 
between logKlipw and logKow (1:1 blue dashed line) and between logKPDMSw and logKow (1:10 black 
dashed line).  
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Section SI-2: Additional information on the mathematics of BEQ. 
The steps to derive the BEQs from experimental data are summarized in Figure SI-2.  
If analytical data are available, BEQchem is defined as the summation of the instrumentally 
determined concentration of a chemical (i) multiplied by its REP to a reference compound towards 
the biological endpoint (equation 2).  
 
∑ )REP(C)g (ngBEQ ilipi,lip-1lip chem, ×=                                              (SI-1) 
BEQchem, lip is the lipid-normalized BEQchem concentrations of the chemical mixture present in the 
tissue, Ci,lip is the lipid normalized concentration of a chemical and REPi is the relative effect 
potency of the chemical in relation to the reference compound if it is assessed in the same assay as 
the environmental samples are tested.  
 
) L(ng (i) EC
) L(ng compound) (reference EC=REP -1
50
-1
50
i                                           (SI-2)  
By substituting equation 2 (main text) into equation SI-2, BEQchem, lip can be back estimated from the 
BEQ of the chemical mixture fraction transferred into PDMS (BEQchem,PDMS) (equation SI-3) and as 
Klip-PDMS is largely independent of hydrophobicity, the geometric mean K (equation SI-4) of all 
measured Klip-PDMS,i values can be used to convert BEQchem,PDMS into BEQchem,lip.  
 
 PDMSchem,
n
1i
iPDMSi,
n
1i
ii PDMS,-lip PDMSi,lip chem, BEQK)REP(CK)REPK(CBEQ ×=×=××= ∑∑
==
 
(SI-3) 
n
n
i
∏
=
=
1
i PDMS,-lipKK                                                  (SI-4) 
The BEQbio is defined as the concentration of a reference compound that causes the same effect as 
the sample and can be calculated as the ratio of the EC50 of the reference compound to the EC50 (in 
units of concentration factor) of the sample in the bioassay (equation SI-5).  
 
) L(g sample of EC
   ) L(ng compound reference of EC=)g (ng BEQ
w
-1
PDMS50
w
-1
50
PDMS
-1
PDMSbio,
                 
(SI-5) 
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In the present study, the dose metric of a sample (PDMS extract) was the concentration factor (CF), 
which was defined by equation SI-6. 
 
(L)bioassay  of volume
  (g)bioassay   toed transferrequivalent mass PDMS=) L(g CF w1-PDMS                 (SI-6) 
 
With the constant K, BEQbio,lip can be deduced from BEQbio,PDMS analogously to BEQchem (equation 
SI-7). 
 
PDMSbio,lip bio, BEQKBEQ ×=                                                (SI-7) 
 
For validation purposes in the spiked experiments, BEQchem equals BEQbio provided that all effect is 
caused by the spiked chemicals. For samples with unknown composition of pollutants, we can 
quantitatively estimate the overall mixture effect burden of chemical mixtures present in the 
biological tissue from screening the fraction extracted by PDMS in in vitro bioassays. The 
difference between BEQchem and BEQbio is then a measure of how much unknown AhR inducers are 
in the sample in addition to the ones quantified with chemical analysis.  
 
 
 
Figure SI-2: Steps of mathematical induction of BEQ.
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Section SI-3: Additional information on the lipid content of the tested blubber samples. 
The lipid content of the dugong samples used in this study was determined gravimetrically. Briefly, 
approximately 8 grams of soft blubber and 4 grams of hypodermis were accurately weighed into 
glass beakers and 40 mL of 4 M HCl was added. The samples were then heated at 70-80˚C for 3-4 
hours. The acid digest was liquid-liquid extracted with 100 mL hexane and 150 mL warm water, 
followed by double extractions with a mix of 50 mL of hexane and 100 mL water. The water 
fractions were then discarded. The hexane fractions were filtered through sodium sulphate and 
concentrated on a rotary evaporator to approximately 1 mL. Subsequently, the fraction was 
transferred to preweighed pear-shaped flasks and further concentrated under a gentle high purity 
nitrogen stream until the weight was stable, and the percent lipid was calculated. 
 
Table SI-1: Lipid content of the tested blubber samples. 
Sample ID Lipid content (%) 
1 11 
2 86 
3 72 
4 68 
5 77 
6 9.9 
7 32 
8 72 
9  76 
10 81 
11 91 
12* 85 
*This blubber sample was used for method validation; all the others for method application.  
 
Section SI-4: Additional information on the procedure and algorithms of the partitioning 
experiment. 
For PDMSBlubber partitioning experiments, PDMS disks were uploaded with dioxins using a 
method modified from Endo et al.4: PDMS disks (1 mm in thickness, 16 mm in diameter and ~235 
mg in weight) were cut from medical grade PDMS sheet (Specialty Silicone Products, Inc. Ballston, 
Spa, NY, USA), soxhlet cleaned (300 ml hexane followed by 300 mL methanol, for 2 hours each) 
and air-dried. 87 µL of PCDD stock solution in toluene (5 µg mL-1) (a total mass of 435 ng for each 
congener) was added to each of six 20 mL glass vials and gently blown down under nitrogen at 
40°C. 500 µL methanol was then added to each vial. A single clean PDMS disk was placed in each 
vial and left overnight on an orbital shaker at 100 rpm at 25°C to allow dissolution and uptake of 
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chemicals into PDMS. The following day Milli-Q water was added in hourly increasing volume (50, 
50, 100, 100, 200 and 1000 µL every hour amounting to a total water volume of 1.5 mL) to each 
vial to force the diffusion of dioxins into PDMS disks, and the vials left overnight on the shaker.  
 
For BlubberPDMS partitioning experiments, 620 µL of PCDD stock solution (5 µg mL-1) was 
gently blown down to near dryness under nitrogen at 40°C in an amber glass vial, and taken up in 
71 µL in toluene, resulting in a concentration of 43.5 µg mL-1. 16 thin blubber slices (approximately 
0.25 g each) were cut, weighed and each of 8 pairs placed in individual wells of a 24-well plate. 
Three of these pairs were spiked with 10 µL of the concentrated PCDD standard and left overnight 
for diffusion of the spiked chemicals into the tissue, and evaporation of the solvent. The remaining 
pairs served as untreated control. The following day, a PDMS disk was sandwiched between each 
blubber pair and left for 24 hours. A full mass balance equation (SI-8) was applied to calculate the 
Klip-PDMS. 
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      (SI-8)
 
Where CPDMS and Clip are the concentration of a dioxin congener in PDMS and lipid, respectively, 
after 24 hour partitioning, which are calculated by dividing the mass of the dioxin congener in 
PDMS (mPCDD,PDMS) or lipid (mPCDD,lipid) by the mass of the corresponding phase mPDMS or mlipid. mlipid 
is calculated using the blubber slice weight (mblubber) and its representative percentage lipid content. 
Assuming negligible loss of dioxins into other phases (which is justified as the results showed that 
both directions yielded the same partition coefficient), mPCDD,lipid is the difference between the mass 
uploaded into PDMS (mPCDD,total) and mPCDD,total and mPCDD,PDMS are the product of the concentration of 
the PDMS extract at the intial time t0 (Cto,extract) or after 24 h (Ct24,extract) and its volume (V). 
 
For the direction from blubber to PDMS, Klip-PDMS was calculated using equation SI-9: 
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(SI-9) 
Where mPCDD,spike represents the mass of a dioxin congener spiked into the blubber, which is 
calculated by multiplying the spiked concentration (Cspike) by the spiked volume (Vspike), and the 
other parameters bear the same meaning of those in eq (SI-1). 
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Table SI-2: Determination of Klip-PDMS in the bi-directional partitioning experiment. 
PDMS  Blubber 
 
TCDD PeCDD HxCDD HpCDD OCDD 
Concentration in the GC vial (ng µl-1) t0 1  9.1 8.8 9.3 9.2 9.1 
 t0 2  8.4 7.5 8.5 8.5 8.3 
 t0 3  8.2 7.6 8.1 8.3 8.3 
 t24 1 0.15 0.11 0.098 0.089 0.077 
 t24 2 0.15 0.092 0.089 0.081 0.089 
  t24 3 0.18 0.12 0.11 0.098 0.094 
Calculation for concentration in PDMS at t=24 h t24 1 mass in PDMS (ng) 11 7.8 7.4 6.7 5.8 
(mPDMS = 0.236 g) t24 2 mass in PDMS (ng) 11 6.9 6.6 6.1 6.7 
 
t24 3 mass in PDMS (ng) 14 8.9 8.6 7.3 7.0 
 
CPDMS 1 (ng g-1) 48 33 31 28 24 
 
CPDMS 2 (ng g-1) 47 29 28 26 28 
 
CPDMS 3 (ng g-1) 57 37 36 31 30 
Calculation for concentration in lipid at t=24 h t0 1 mass in PDMS (ng) 454 437 462 459 454 
(mlipid = 0.43 g) t0 2 mass in PDMS (ng) 419 375 423 424 415 
 
t0 3 mass in PDMS (ng) 410 378 407 414 413 
 
Mass depleted into blubber 1 (ng) 416 389 423 426 422 
 
Mass depleted into blubber 2 (ng) 416 390 424 426 421 
 
Mass depleted into blubber 3 (ng) 414 388 422 425 421 
 
Clip 1 (ng g-1) 971 907 989 993 984 
 
Clip 2 (ng g-1) 975 913 993 998 986 
 
Clip 3 (ng g-1) 972 911 992 998 987 
Calculation for Klip-PDMS (gPDMS g-1lip) Klip-PDMS 1  20 27 31 35 40 
 
K lip-PDMS 2 20 31 35 38 35 
 
K lip-PDMS 3 17 24 27 32 33 
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Table SI-2 (continued) 
Blubber  PDMS 
 
TCDD PeCDD HxCDD HpCDD OCDD 
Concentration in the GC vial (ng µl-1) t=24 h 1 0.19 0.14 0.13 0.11 0.10 
 t=24 h 2 0.15 0.11 0.092 0.086 0.085 
  t=24 h 3 0.15 0.10 0.095 0.082 0.080 
Calculation for concentration in PDMS at t=24 h Mass in PDMS 1 at t=24 h (ng) 14 10 9.7 8.0 7.6 
 
Mass in PDMS 2 at t=24 h (ng) 12 8.0 6.9 6.5 6.4 
 
Mass in PDMS 3 at t=24 h (ng) 11 7.5 7.1 6.2 6.0 
 
CPDMS 1 (ng g-1)* 61 34 29 27 27 
 
CPDMS 2 (ng g-1)* 47 43 41 34 32 
 
CPDMS 3 (ng g-1)* 48 32 30 26 26 
Calculation for concentration in lipid at  
t=24 h Spiked concentration (ng µl-1) 48 43 46 45 46 
 
Mass spiked into blubber (ng) 481 434 457 454 457 
 
Mass remaining in blubber 1 (ng) 466 471 471 473 473 
 
Mass remaining in blubber 2 (ng) 469 473 474 474 474 
 
Mass remaining in blubber 3 (ng) 469 473 474 475 475 
 
Clip 1 (ng g-1) 1,089 1,099 1,100 1,104 1,105 
 
Clip 2 (ng g-1) 1,105 1,113 1,115 1,116 1,117 
 
Clip 3 (ng g-1) 1,101 1,111 1,111 1,113 1,113 
Calculation for Klip-PDMS (gPDMS g-1lip) Klip-PDMS 1  18 32 37 40 40 
 
Klip-PDMS 2 23 25 27 32 34 
 
Klip-PDMS 3 22 34 36 42 43 
*These three extracts correspond to those in Table SI-5 and 6 and the concentrations of PCDD congeners are used to calculate BEQchem values. 
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Section SI-5: Additional information on lipid uptake into PDMS. 
To understand the uptake of lipid into the PDMS disk, we used a microbalance (smallest scale of 0.001 
mg) to monitor the weight change of three PDMS disks throughout the whole procedure of the partition 
experiment with unspiked blubber slices. To ensure there is no residue remaining on the PDMS surface, 
PDMS disks were quickly dipped into acetone and wiped with lint-free tissue paper, and the cleaning 
was repeated three times. As our tested blubber contained 85% lipid content, we assumed that the net 
weight gain was the amount of lipid that diffused into the PDMS not from other tissue components 
(proteins, water). 
 
Table SI-3: Weight (mg) change of PDMS throughout the experimental procedure. 
 
PDMS 1 PDMS 2 PDMS 3 
Initial weight 233.69 236.73 234.25 
After 24 h contact without wiping 250.80 254.01 255.42 
After thorough wiping with acetone 234.91 238.18 235.57 
Weight confirmation the following day 234.90 238.17 235.59 
Net weight gain 1.21 1.44 1.34 
% weight gain 0.51 0.60 0.57 
 
Section SI-6: Additional information on quantification of PCDD/Fs in dugong blubber. 
Target analytes were the seventeen 2,3,7,8-substituted PCDD/Fs. Analyses were carried out using a 
high-resolution gas chromatograph high-resolution mass spectrometer (HRGC-HRMS) at ERGO 
Forschungsgesellschaft mbH in Germany, which is accredited according to ISO 17025 and regularly 
participates in interlaboratory studies relating to the analyses of PCDD/Fs in biological tissues, 
including fish. 
 
Samples were extracted either using a cold extraction (10-40 g ww of lipid poor blubber) or acid digest 
(1-3 g ww lipid rich blubber) methods. For cold extraction, tissue was homogenized in a stainless steel 
blender, mixed with anhydrous sodium sulphate to create a free flowing mixture,, extracted 
ultrasonically with a mixture of n-hexane/acetone (1:1, v:v) and concentrated. Acid digestion was 
carried out in 150 mL of 4 molar HCl at 60 ⁰C for 2-4 hours, followed by triplicate liquid:liquid 
extraction in hexane:water (1:3, v:v); extracts were then filtered through ~3 g Na2SO4 and concentrated. 
Approximately 1-3 g of yielded lipid was spiked with quantification standards (internal standards) 
using all PCDD/F analytes as 13C-labeled compounds, except for 1,2,3,7,8,9-HexaCDD (1,2,3,6,7,8-
HexaCDD was used). 
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The clean-up consisted of a sulfuric acid coated silica gel (~6-12 g) pre-treatment, followed by 
fractionation on active carbon (Supelco SupelcleanTM ENVI-Carb SPE tube). PCDD/Fs were eluted 
with 50 mL toluene in the reverse direction. This was followed by chromatography with a combination 
of columns using cesium coated silica gel, sulfuric acid coated silica gel followed by alumina (elution 
with 25 mL hexane:DCM (1:1, v:v)) and florisil (elution with 120 mL toluene). The fractions were 
evaporated and a set of four 13C-PCDD/Fs were added as injection standards. Analytical measurement 
was performed by HRGC/HRMS on a Waters Autospec HRMS at mass resolution R  10,000 
equipped with a DB5ms-type fused silica column (60m × 0.32mm i.d. × 0.25µm dF). Quantification 
was carried out by isotope dilution against daily calibration points together with a multipoint 
calibration.  
 
For quality control, method blanks were run with each sample batch to monitor for possible 
background contamination. Reference materials (routinely run in-house pooled fish oil) were regularly 
monitored to test reproducibility. 
 
Analytes were accepted for quantification if their retention times were within 2 seconds of the retention 
times of the relevant labelled internal standards and the ratios for the area of the two most abundant 
isotopes were within 20% of their calculated values. The limit of quantification (LOQ) for PCDD/F 
was defined as a signal–to-noise ratio greater than 3 times the average baseline variation. BEQchem of 
each sample was calculated using CAFLUX-derived REP values. 
 
 
Figure SI-3: Long-term record of EC50 of the reference compound, TCDD. The filled diamonds are the 
valid repeats and the empty diamonds are the repeats that were excluded. 
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Section SI-7: Error propagation. 
Error was propagated for EC50 and REP of each PCDD congener and BEQchem and BEQbio of samples 
using the following equations (SI-9-12). The standard error of logEC50 for each compound and sample 
was initially provided in the sigmoidal curve fitting and given to propagate the error for REP and BEQ 
according to their mathematical relationships. 
 
 
                                                (SI-9) 
 
 
                               (SI-10) 
 
                               (SI-11) 
50#
#
 
                             
                                                                                                                                                 (SI-12) 
 
Table SI-4: Combined concentration-response curves (n=21 for TCDD and n=4 for the other 
congeners) and EC50 and REP values of each PCDD congener. 
Concentration-response curve Congener EC50 (ng L
-1) 
(95% CI) 
REP 
(±standard error)* 
  
TCDD 7.7 (7.4-8.0) 1.0±0.1 
PeCDD 6.9 (6.0-7.9) 1.1±0.2 
HxCDD 22 (19-26) 0.3±0.01 
HpCDD 80 (73-87) 0.09±0.00 
OCDD 2613 (2398-2847) 0.002±0.000 
*Calculated by error propagation (Section SI-7, equation SI-9). 
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Table SI-5: BEQchem derivation of the triplicate PDMS extracts from spiked blubber. 
Extract 
BEQchem of each congener (ng g-1PDMS)* BEQchem  
(ng g-1PDMS) 
(±standard error)# 
Average  
(ng g-1PDMS) 
(±standard error) TCDD PeCDD HxCDD HpCDD OCDD 
1 49 41 9 2.7 0.1 101±20  
109±20 2 61 52 12 3.4 0.1 128±25 
3 48 38 9 2.6 0.1 98±19 
*Calculated using the concentrations in Table SI-2 and REPs in Table SI-4. 
#Calculated by error propagation (Section SI-7, equation SI-10). 
 
Table SI-6: Concentration-response curves and BEQbio derivation of the triplicate PDMS extracts from 
spiked blubber. 
Extract Concentration-response curve 
EC50  
(CF (g L-1)) 
(95% CI) 
BEQbio  
(ng g-1PDMS) 
(±standard error)* 
Average  
(ng g-1PDMS) 
(±standard error) 
1 
  
0.074 
(0.061-0.091) 108±5 
 
108±8 
 
2 0.069 (0.056-0.085) 115±7 
3 0.080 (0.064-0.010) 100±2 
*Calculated by error propagation (Section SI-7, equation SI-11). 
 
Section SI-8: Additional information on concentration-response curves of dugong sample extracts 
and derivation of method detection limit, EC50 and BEQ. 
The method detection limit (MDL) was calculated against the dose-response curve of TCDD standard. 
Detectable response in the bioassay (7.2%) was defined as three times of the percentage induction of 
controls (2.4%). Based on the sigmoidal dose-response curve averaged for all 21 replicates that were 
determined during the course of the study (Table SI-4 with the equation: % max TCDD induction = 
100 / (1+10(0.8882-log Cnominal))). The detection limit of the bioassay was calculated to be 0.6 ng L-1. The 
detectable mass was thus 0.06 pg TCDD equivalent in a 100 µL well, which is transferred from lipid 
into PDMS equivalent to half a disk mass (approx. 0.235 g per PDMS), as we splitted each sample 
extract from one PDMS disk in half to have the optimal lipid amount that does not interfere with 
CAFLUX. The concentration of 0.5 pg g-1PDMS was then converted to the bioanalytical method detection 
limit of 15 pg g-1lip in the dugong blubber by applying the generalized Klip-PDMS of 30. 
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Table SI-7: Concentration-response curves (n=6) and BEQ derivations of dugong blubber samples. 
Sample 
ID 
Concentration-response 
curve 
Significantly 
higher than PDMS 
blank? 
R2 EC50  (g L-1) 
BEQbio, PDMS 
(pg g-1PDMS) 
> detection limit of 
0.5 pg g-1PDMS? 
BEQbio,lip  
(pg g-1lip) 
(±standard 
error) 
BEQchem,lip 
(pg g-1lip) 
(±standard 
error) 
PDMS 
blank 
 
N/A N/A N/A N/A N/A N/A 
 
 
N/A 
 
 
1 
 
Yes 0.5853 2658 2.9 Yes 81±20 
 
18±4 
 
2 
 
Yes 0.2849 3466 2.2 Yes 62±15 
 
45±9 
 
         
*Section SI-7, equation SI-12. 
 #Section SI-7, equation SI-11. 
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Table SI-7 (continued) 
Sample 
ID 
Concentration-response 
curve 
Significantly 
higher than PDMS 
blank? 
R2 EC50  (g L-1) 
BEQbio,PDMS  
(pg g-1PDMS) 
> detection limit of 
0.5 pg g-1PDMS? 
BEQbio,lip  
(pg g-1lip) 
(±standard 
error)* 
BEQchem,lip 
(pg g-1lip) 
(±standard 
error)# 
3 
 
No N/A N/A N/A N/A N/A 5.7±1.1 
4 
 
No N/A N/A N/A N/A N/A 13±2.7 
5 
 
Yes 0.6605 2433 3.2 Yes 89±21 53±11 
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Table SI-7 (continued) 
Sample 
ID 
Concentration-response 
curve 
Significantly 
higher than PDMS 
blank? 
R2 EC50  (g L-1) 
BEQbio,PDMS  
(pg g-1PDMS) 
> detection limit of 
0.5 pg g-1PDMS? 
BEQbio,lip  
(pg g-1lip) 
(±standard 
error) 
BEQchem,lip 
(pg g-1lip) 
(±standard 
error) 
6 
 
Yes 0.6144 2140 3.6 Yes 101±25 92±18 
7 
 
Yes 0.5886 1152 6.7 
 
Yes 
 
188±45 259±52 
8 
 
Yes 0.4068 3475 2.2 
 
 
Yes 
 
 
62±14 26±5 
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Table SI-7 (continued) 
Sample 
ID 
Concentration-response 
curve 
Significantly 
higher than PDMS 
blank? 
R2 EC50  (g L-1) 
BEQbio,PDMS 
(pg g-1) 
> detection limit of 
0.5 pg g-1PDMS? 
BEQbio,lip  
(pg g-1lip) 
(±standard 
error) 
BEQchem,lip 
(pg g-1lip) 
(±standard 
error) 
9 
 
No N/A N/A N/A N/A N/A 2.4±0.5 
10 
 
No N/A N/A N/A N/A N/A 14±2.9 
11 
 
No N/A N/A N/A N/A N/A 10±2.1 
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Chapter IV. Adaptive Stress Response Pathways Induced by 
Environmental Mixtures of Bioaccumulative Chemicals in Dugongs 
 
Reprinted with permission from: Jin, L., Gaus, C. and Escher, B.I. 2015. Adaptive stress response 
pathways induced by environmental mixtures of bioaccumulative chemicals. Environmental Science 
& Technology 49, 6963–6973. Copyright (2015) American Chemical Society. 
 
This chapter is an application of the PDMS-based passive sampling technique, which was validated 
in Chapter III, to toxicological profiling of bioaccumulative chemical mixtures in the marine 
mammal dugong. Echoing the toxicity pathway-based vision (reviewed in Chapter II), we employed 
a panel of cell-based bioassays indicating several early molecular events of toxicity pathways as 
biologically relevant exposure indicators. Individual chemicals and dugong blubber samples were 
screened in the assay test battery. To quantitatively link chemical exposure to mixture effects, the 
contribution was evaluated of certain POPs to the overall toxicologically relevant chemical burden 
in dugong samples. The utility of incorporating metabolic enzymes in bioassays was evaluated. 
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Table SI-1: Additional information about dugong samples. 
Sample no. Year of collection Sex Age group 
01 1999 Male Adult 
02 1999 Female Unknown 
03 1999 Male Unknown 
04 1999 Female Adult 
05 1999 Male Juvenile 
06 1999 Male Adult 
07 1999 Female Adult 
08 1999 Male Unknown 
09 1999 Female Unknown 
10 1999 Unknown Unknown 
11 1999 Female Unknown 
12 2000 Female Adult 
13 2001 Female Adult 
14 2002 Male Adult 
15 2002 Unknown Adult 
16 2004 Male Adult 
17 2004 Male Calf 
18 2004 Male Adult 
19 2005 Female Adult 
20 2004 Male Adult 
21 2006 Male Adult 
22 2009 Female Adult 
23 2006 Female Sub-Adult 
24 2006 Female Adult 
25 2007 Male Adult 
26 2007 Female Adult 
27 2011 Male Juvenile 
28 2011 Unknown Unknown 
29 2011 Female Adult 
30 2011 Male Juvenile 
31 2011 Male Adult 
32 2011 Female Adult 
33 2012 Male Juvenile 
34 1998 Female Adult 
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Section SI-1: Determination of lipid content of dugong blubber samples. 
Determination of dugong blubber lipid content followed the procedure described previously.1 
Briefly, approximately 8 g of soft blubber was weighed in a glass beaker. The samples were then 
heated at 70-80˚C for 3-4 hours in 40 mL of 4 M HCl. The acid digest was subject to liquid-liquid 
extraction with 100 mL of hexane and 150 mL of warm water, and subsequently double extractions 
with 50 mL of hexane and 100 mL of water. The hexane fractions were collected, filtered through 
sodium sulphate, and reduced to approximately 1 mL on a rotary evaporator. The concentrated 
extract was then transferred to a preweighed glass vial and further concentrated under a gentle 
stream of nitrogen gas until the weight was stable. The blubber lipid weight was obtained to 
calculate the percentage lipid content (Table SI-2). 
 
Table SI-2: Lipid content of the tested blubber samples. 
Sample ID Lipid content (%)  Sample ID Lipid content (%) 
01 21  18 61 
02 79  19 43 
03 68  20 77 
04 72  21 84 
05 83  22 59 
06 64  23 73 
07 36  24 92 
08 75  25 72 
09  77  26 76 
10 69  27 80 
11 85  28 91 
12 81  29 85 
13 54  30 69 
14 73  31 65 
15 82  32 74 
16 49  33 58 
17 57  34 89 
 
Lipid content is an important parameter affecting 1) the time for PDMS-blubber partitioning 
equilibrium; and 2) the sorptive capacity of the blubber for bioaccumulative chemicals and hence 
the accuracy of normalizing concentrations on a lipid content basis. Jahnke et al.2 demonstrated that 
hydrophobic chemicals like PCBs can reach equilibration in the range of hours between PDMS and 
fish tissue with 20% lipid content. They also demonstrated that the lipid-normalized PCB 
concentrations in such fish tissue determined using the passive sampling method agree with those 
using the conventional exhaustive extraction method,3 suggesting lipid as dominant sorptive phase 
in the fish tissue at the 20% content level. While we identified four low values of lipid content 
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(20%-50%) as outliers statistically that skewed the normal distribution of the 34 samples (Figure 
SI-1), the lipid content values measured for dugong blubber would not cause discrepanicies among 
samples in equilibration time and result expression on the lipid-normalized basis, and therefore 
outliers were included in the analysis.  
 
Figure SI-1: Distribution of lipid content values. 
 
Section SI-2: The influence of co-extracted lipid on the true Klip-PDMS value. 
Klip-PDMS is the reciprocal of KPDMS-lip (=1/Klip-PDMS or 1/30), which is calculated as the ratio of the 
equilibrium concentration of a chemical (i) measured in PDMS to that in lipid (Ci,lip). The measured 
chemical concentration in PDMS consists of two parts: 1) the true concentration in PDMS (Ci,PDMS); 
and 2) the mass of the chemical in co-extracted lipid normalized to PDMS weight (mi,lip in 
PDMS/mPDMS). 
lipi,
PDMS
 PDMSin lipi,
PDMSi,
measuredlip,PDMS C
m
m
C
K
+
=−                                          (SI-1) 
 
lipi,
PDMSi,
truelip,PDMS C
C
K =−                                                        (SI-2) 
 
Assuming that the concentration of the chemical in co-extracted lipid is equal to that in blubber 
lipid, 
 PDMSin lip
 PDMSin lipi,
lip
lipi,
lipi, m
m
m
m
C ==                                                    (SI-3) 
Thus, 
 PDMSin liplipi, PDMSin lipi, mCm =                                                   (SI-4) 
 
Substituting eq (SI-4) into eq (SI-1), 
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PDMS
 PDMSin lip
truelip,PDMSmeasuredlip,PDMS m
m
KK += −−                                    (SI-5) 
 
In our previous study,1 we demonstrated that the lipid diffused into PDMS accounts for a constant 
weight gain of 0.6% (mlip in PDMS/mPDMS = 0.6% or 6 mglip gPDMS-1) in PDMS under the current mass 
ratio of blubber to PDMS. With KPDMS-lip,measured known to be 1/30, Klip-PDMS,true, the reciprocal of 
KPDMS-lip,true, is calculated to be 37. Klip-PDMS,measured is 18% lower than Klip-PDMS,true, and, in turn, the 
measured chemical concentration in PDMS would be higher than the true one by 18%, which is 
contributed by the co-extracted lipid by PDMS. However, as long as we used the constant Klip-
PDMS,measured of 30 consistently across samples, the relative comparison between samples would not 
be affected. 
 
Section SI-3: Time-dependency of Nrf2-mediated oxidative stress response to select chemicals 
in the AREc32 assay 
We evaluated the time-dependency of concentration-response to three reference compounds in the 
AREc32 assay to determine the optimal exposure period for endpoint measurement. tert-
Butylhydroquinone (tBHQ) caused the maximum  induction after 24 hours and consistently 
decreased after 48 and 72 h (Figure SI-2A). TCDD showed no time-dependence of induction 
(Figure SI-2B). BaP exhibited a remarkable increase in induction after 48 hours and further slight 
increase after 72 hours compared to 24 hours (Figure SI-2C). The pattern of time-dependency in 
response to these three chemicals appears to reflect that of the metabolic degradation (e.g., tBHQ), 
inertness (e.g., TCDD) and activation (e.g., BaP). Therefore, we used the 24-h exposure period to 
measure the induction effect of chemicals and samples, and incorporated rat liver S9 enzyme 
cocktails as an alternative to longer exposure periods. 
 
Figure SI-2: Oxidative stress response to reference chemicals (A) tBHQ, (B) TCDD and (C) BaP 
with time in the AREc32 assay 
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Section SI-4: Additional information on the NF-κB-THP1-bla assay. 
The commercially available CellSensor® NF-κB-bla THP-1 Cell Line developed by Invitrogen was 
used to measure the NF-κB activation 
(https://tools.lifetechnologies.com/content/sfs/manuals/CellSensor_NFkBbla_THP1_man.pdf). The 
THP1 human leukemia cells are stably transfected with a β-lactamase reporter gene downstream of 
NF-κB response element. This assay, similar to the p53-bla assay,4 applies a fluorescence resonance 
energy transfer (FRET) technique for quantitative measurement of the β-lactamase activity, which 
indicates the activation of NF-κB.  
 
Cell medium is loaded with the esterified and lipophilic LiveBLAzer FRET-B/G CCF4-AM dye, 
which is able to readily enter the cells. Hydrolysis by cytoplasmic esterases rapidly converts the dye 
into a negatively charged substrate molecule. The substrate retains in the cells and contains two 
fluoroprobes, coumarin and fluorescein. In the absence of β-lactamase expression, the substrate 
molecule remains intact, and excitation of the coumarin (at 409 nm) results in FRET to the 
fluorescein moiety, which emits a green fluorescence signal (at 530 nm). In the presence of β-
lactamase expression, the lactam ring of the substrate molecule is enzymatically cleaved, separating 
the fluorophores spatially and disrupting FRET, so that excitation of the coumarin (at 409 nm) 
produces a blue fluorescence signal (460 nm). The resulting blue:green ratio provides a normalized 
reporter response, thus offering a quantitative measure of NF-κB activation. 
 
Experiments were performed by simultaneously measuring the NF-κB activity as well as the 
cellular mitochondrial activity by means of the resazurin conversion using 50 µM final resazurin 
concentration.4 Enzymatic reduction of resazurin to resorufin occurs in cells with active 
mitochondrial metabolism, thus serving as a reliable indicator of cell viability. 
 
Cells were plated in black-coated clear-bottom 384-well Falcon BD plates at a density of 6.25×105 
cells/mL and were allowed to grow for >6 hours. Dosing was performed by adding 8 µL of assay 
medium containing 0.5% DMSO and test chemicals or sample mixtures to the cells (32 µL assay 
medium) leading to a final DMSO concentration of 0.1%. Plates were sealed with Breathe-Easy 
sealing membrane (Sigma-Aldrich) and incubated at 37°C and 5% CO2 after dosing. Different 
periods of exposure were attempted to determine the optimal reading timeframe, considering the 
toxicokinetics of test chemicals (discussed further below). Afterwards, 8 µL of the LiveBLAzer mix 
and resazurin solution was added and incubated for 2 h at room temperature prior to measurements.  
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Fluorescent measurements were performed with the FLUOstar Omega plate reader (BMG Labtech) 
and MARS version 2.10 software. The fluorescent emission resulting from resazurin exposure for 2 
h was measured at 590 nm after excitation at 544 nm. The effective concentration causing 10% cell 
viability decline (EC10) was estimated using sigmoidal curve fitting.5 Concentrations of test 
chemicals or samples higher than EC10 were excluded from further analysis of endpoint induction. 
 
CCF4 was excited at 409 nm and emission was measured at 460 (blue channel) and 530 nm (green 
channel) according to the manufacturer’s instructions 
(http://tools.lifetechnologies.com/content/sfs/manuals/CellSensor_NFkBbla_THP1_man.pdf). The 
fluorescence data were corrected by the average of eight cell free blank wells (assay medium 
without cells). The blue/green emission ratio indicated the NF-κB induction, and the induction ratio 
was calculated by dividing the blue/green emission ratio of a sample by the average emission ratio 
of the solvent control. 
 
We tested the time-dependency of dose-response for tumor necrosis factor-alpha (TNF-α; 
Invitrogen) and E.coli lipopolysaccharide (LPS), which are well-known reference chemicals 
activating NF-κB via binding to the TNF-α receptor and Toll-like receptor, respectively, located at 
the cell membrane. Of the time series tested, NF-κB activity peaked upon 5-h cell exposure TNF-α 
or LPS, significantly dropped after 24 h and showed an even drastic decline after 48 or 72 h (Figure 
SI-3). The results agreed with the manufacturer’s protocol of using the 5-h exposure period as well 
as similar patterns observed in immunological studies.6, 7 However, no experimental evidence has 
proved that the bioaccumulative chemicals tested in this study are ligands of such membrane 
receptors as Toll-like receptor and TNF-α receptor. We reasoned that should there be an effect of 
these chemicals on NF-κB, diffusion into cells may be required to trigger a response. Unlike the 
rapid response to TNF-α or LPS at the cell membrane, the diffusion kinetics of bioaccumulative 
chemicals across the membrane into the cell is far slower. Thus we chose the 24-h exposure period 
as a compromise to allow the tested chemicals reach equilibration in the in vitro system while 
maintaining a suitable dynamic response range of those chemicals acting via membrane receptors. 
TNF-α was assigned as the reference compound for the assay with an ECIR1.5 of 34.7±3.1 ng L-1.  
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Figure SI-3: Time dependent dose response curves of NF-κB activation by (A) TNF-α and (B) LPS. 
!
Section SI-5: Estimation of saturated medium concentrations for different bioassays. 
When dosing hydrophobic chemicals, such as PCDDs, PCBs and PAHs, it is important to correct 
nominally dosed concentrations for their solubility limits in the assay medium so that the effective 
concentration derived for each biological endpoint is valid. In the following we describe a mass 
balance model to estimate the maximum soluble medium concentrations to assure that all chemicals 
were dissolved in the experiments. Nevertheless, effect concentration (EC) values are reported as 
nominal concentrations and were not corrected for binding to medium component and cells. 
!
Considering water, proteins and lipid as the major phases relevant for chemical sorption in the in 
vitro system, the medium concentration (Cmedium) of a chemical in an in vitro bioassay can be 
estimated using equation SI-1 based on its aqueous concentration (Cw), bovine serum albumin- and 
liposome-water partition coefficients (KBSAw and Klipw), concentrations of proteins (mprotein/VFBS) 
and lipid (mlip/VFBS) in the supplement fetal bovine serum (FBS) and the volume ratio of FBS and 
medium (VFBS/Vmedium). 
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Assuming that the partitioning of a chemical between the sorptive phases is linear up to its 
solubility limit, its saturated medium concentration (Cmediumsat) can thus be calculated with its water 
solubility (Cwsat) and all the other parameters mentioned above using equation SI-2. 
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The concentration of proteins in FBS was determined with the Lowry method and was mprotein/VFBS 
= 43.1±3.1 gprotein/LFBS (Ben Mewburn, Entox, The University of Queensland, 2012, unpublished 
results). The lipid content was determined with the phosphovanilline method8 modified according to 
Kretschmann et al.9 and was mlip/VFBS = 1.1±0.3 gprotein/LFBS (Ben Mewburn, Entox, The University 
of Queensland, 2012, unpublished results). The lipid and protein content of cells was neglected in 
this mass balance calculation because it is small as compared to serum proteins and lipid. The 
volume ratio of FBS and medium (VFBS/Vmedium) was 10% for CAFLUX and AREc32, and 0.5% for 
p53 and NF-κB assays according to the assay protocols. 
 
The values of Cwsat,10-17 logKow,18 logKBSAw,19 logKlipw,20 and  hence estimated Cmediumsat are 
tabulated in Table SI-3. The logKBSAw values for PCDDs, PCB congeners, B[a]P, BDE 209, p,p’-
DDT, -DDD and –DDE, HCB, bifenthrin and permethrin, their logKBSAw values were estimated 
using the QSAR equation (KBSAw = 0.05Kow).21 The logKlipw values for the four PCB congeners, 
BDE 209, p,p’-DDT, -DDD and –DDE, γ-HCH, bifenthrin and permethrin were estimated using the 
QSAR equation (logKlipw = logKow + 0.14).1 
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Table SI-3: Physicochemical parameters required for estimating saturated medium concentrations for tested compounds in different bioassays. 
Compound logKow18 
MW 
(g mol-1) 
Cwsat 10-17 
(µg L-1)
  
Cwsat 
(M) 
logKBSAw19 
(L kg-1)  
logKlipw20 
(L kg-1)  
Cmediumsat (M) 
CAFLUX AREc32 p53-bla NF-κB-bla 
TCDD 6.67 322.0 0.0193 6.0×10-11 5.37 6.90 1.1×10-7 1.1×10-7 5.6×10-9 5.6×10-9 
PeCDD 7.08 356.4 0.0103 2.9×10-11 5.78 7.07 1.1×10-7 1.1×10-7 5.6×10-9 5.6×10-9 
HxCDD 7.56 390.9 0.0042 1.1×10-11 6.26 7.15 1.0×10-7 1.0×10-7 5.0×10-9 5.0×10-9 
HpCDD 8.17 425.3 0.0024 5.6×10-12 6.87 7.01 1.9×10-7 1.9×10-7 9.3×10-9 9.3×10-9 
OCDD 8.64 459.8 0.0004 8.7×10-13 7.34 7.33 8.4×10-8 8.4×10-8 4.2×10-9 4.2×10-9 
PCB 52 6.34 292.0 46 1.6×10-7 5.04 6.48 1.2×10-4 1.2×10-4 6.4×10-6 6.4×10-6 
PCB 101 6.80 326.4 13 4.0×10-8 5.50 6.94 5.6×10-5 5.6×10-5 2.8×10-6 2.8×10-6 
PCB 126 6.98 326.4 7.3 2.2×10-8 5.68 7.12 5.3×10-5 5.3×10-5 2.7×10-6 2.7×10-6 
PCB 169 7.41 360.9 0.51 1.4×10-9 6.11 7.55 1.3×10-5 1.3×10-5 6.6×10-7 6.6×10-7 
BaP 6.44 252.3 3.8 1.5×10-8 5.14 7.08 2.8×10-5 2.8×10-5 1.4×10-6 1.4×10-6 
Pyr 4.88 202.3 135 6.7×10-7 4.76 5.71 2.0×10-4 2.0×10-4 1.1×10-5 1.1×10-5 
Phe 4.46 178.2 1,290 7.2×10-6 4.15 4.95 5.2×10-4 5.2×10-4 3.3×10-5 3.3×10-5 
BDE 47 6.81 485.8 11 2.3×10-8 5.81 6.95 8.4×10-5 8.4×10-5 4.2×10-6 4.2×10-6 
BDE 209 9.87 959.2 0.004 4.2×10-12 8.57 10.01 1.1×10-5 1.1×10-5 5.6×10-7 5.6×10-7 
p,p'-DDT 6.91 354.5 5.5 1.6×10-8 5.61 7.05 4.6×10-5 4.6×10-5 2.3×10-6 2.3×10-6 
p,p'-DDD 6.02 320.1 67 2.1×10-7 4.72 6.16 8.0×10-5 8.0×10-5 4.2×10-6 4.2×10-6 
p,p'-DDE 6.51 318.0 25 7.9×10-8 5.21 6.65 9.2×10-5 9.2×10-5 4.7×10-6 4.7×10-6 
HCB 5.31 284.8 100 3.5×10-7 4.01 5.64 3.2×10-5 3.2×10-5 1.9×10-6 1.9×10-6 
γ-HCH 3.61 290.8 7,300 2.5×10-5 2.46 3.75 7.1×10-5 7.1×10-5 2.7×10-5 2.7×10-5 
Bifenthrin 6.48 422.9 14 3.3×10-8 5.18 6.62 3.6×10-5 3.6×10-5 1.8×10-6 1.8×10-6 
Permethrin 6.10 391.3 11 2.8×10-8 4.80 6.24 1.3×10-5 1.3×10-5 6.7×10-7 6.7×10-7 
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Section SI-6: Additional information on incorporation of rat liver S9 enzyme cocktails 
in the AREc32 bioassay. 
The protocol of incorporating rat liver S9 fraction and associated metabolic cofactors in the 
AREc32 was adapted from those well established for the umuC genotoxicity assay. The final 
medium concentrations of rat liver S9 fraction 1% (v/v) and two cofactors, namely 
nicotinamide adenine dinucleotide phosphate (NADP; 3.5 mM) and glucose 6-phosphate 
(G6P; 0.5 mM) were kept the same as those used in the umuC assay. The concentration of S9 
proteins in the AREc32 assay was also the same as the optimal one used in other mammalian 
cell-based genotoxicity22 and skin sensitization assays.23  
 
To check if the addition of rat liver S9 fraction and associated metabolic cofactors would 
cause changes in background oxidative stress response levels, we monitored the luciferase 
activity in absolute control wells (cells only) and S9 blank wells (cells with S9 only) on each 
plate for metabolic activation testing of individual compounds or sample extracts throughout 
the experiment. The relative light units (RLU) in each of these wells (n=360) were 
normalized to the average RLU of absolute controls to obtain the background induction ratios 
(IR) for the two control groups (-/+S9) (Equation SI-3).   
control S9-
control S9/-
 RLUaverage
RLUIR +=
                      
(SI-8)  
The difference in background IR was negligible with +S9 controls lower than -S9 controls by 
2% (Figure SI-4), although the difference is statistically significant (t-test, p=0.0383). 
Therefore, S9 addition did not alter background oxidative stress response levels in cells and 
hence did not interfere with measurement and interpretation in compound and sample testing. 
 
Figure SI-4: Comparison of background induction ratios between control groups with and 
without S9 addition. 
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Section SI-7: Additional information on quantification of dioxins in dugong blubber. 
Target analyses for 2,3,7,8-substituted PCDDs were carried out using a high-resolution gas 
chromatograph high-resolution mass spectrometer (HRGC-HRMS) at ERGO 
Forschungsgesellschaft mbH in Germany. 
  
Homogenized dugong blubber samples were mixed with sodium sulfate to create a free 
flowing mixture, which underwent ultrasonic extraction was carried out with a mixture of n-
hexane/acetone. Samples were extracted by a specialized liquid-liquid extraction with n-
hexane followed by n-hexane/i-propanol. All samples were spiked with quantification 
standards (internal standards) prior to extraction containing all 2,3,7,8-substituted PCDD 
analytes as 13C-labeled compounds (exception: 1,2,3,7,8,9-HxCDD). The obtained raw 
extract was gently evaporated and the yielded lipids were used for clean-up.  
 
The clean-up consisted of a sulfuric acid treatment and a fractionation on active carbon for 
separation of PCDDs. This was followed by column chromatography with a combination of 
columns using silica modified with sulfuric acid, basic alumina (activity super I) and florisil. 
Elution was carried out with hexane, toluene and dichloromethane. The fractions were 
evaporated and four 13C-PCDDs standards were added as injection standards. Analytical 
measurement was performed by HRGC/HRMS on a Waters Autospec HRMS at mass 
resolution R ≥ 10,000 equipped with a DB5 ms-type fused silica column (60m × 0.32mm i.d. 
× 0.25µm dF). Quantification was carried out by isotope dilution against daily calibration 
points together with a multipoint calibration.  
 
For quality control, method blanks were run with each sample batch to monitor for possible 
background contamination. Reference materials (pooled samples) were regularly monitored. 
Analytes were accepted for quantification if their retention times were within 2 seconds of the 
retention times of the relevant labeled internal standards and the ratios for the area of the two 
most abundant isotopes were within 20% of their calculated values. The limit of detection 
(MDL) for PCDDs was defined as a signal–to-noise ratio greater than 3 times the average 
baseline variation. 
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Table SI-4: Concentrations (pg glip-1) of select PCDD congeners in blubber samples. 
Sample no. TCDD PeCDD HxCDD HpCDD OCDD 
1 <MDL 5.63 27.1 37.5 109 
2 2.22 20.4 54.6 44.7 56.2 
3 0.0966 0.75 3.01 39.8 105 
4 0.386 5.31 17.2 15.5 17.9 
5 1.61 13.3 75.8 149 417 
6 8.50 42.1 109 50.6 41.2 
7 0.579 5.77 35.2 90.9 243 
8 9.85 81.4 372 519 920 
9 0.708 3.92 20.3 32.3 84.0 
10 0.225 2.85 14.8 22.1 97.3 
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Section SI-8: Additional information on method detection limit for each bioassay. 
The method detection limit was calculated from the dose-response curve of the reference 
compound in each corresponding bioassay (Table SI-5). The detectable response in the 
bioassay was defined as three times the standard deviation (SD) of the average control 
response (percentage effect for CAFLUX; IR for the other bioassays), based on the dose-
response curve of reference compounds averaged for all replicates that were determined 
during the course of the study.  
response controlresponse control SD 3   Mean response Detectable ⋅+=                   (SI-9) 
The detectable assay response was then translated to the detectable concentration of the 
reference compound in the corresponding bioassay using the corresponding dose-response 
curves equations.  
 
For CAFLUX with log-logistic concentration-response curves, 
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For the other bioassays with linear concentration-response curve equations, 
slope
1 - (IR) response Detectable  ) L(ngionconcentrat Detectable 1-compound reference =           (SI-11) 
The detectable concentration of the reference compound in the corresponding bioassay was 
normalized to the amount of PDMS employed during extraction, which was further translated 
to the overall bioanalytical method detection limit (MDL) on a lipid-normalized basis by 
applying the generalized Klip-PDMS of 30. 
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Table SI-5: MDL for each bioassay. 
Bioassay Detectable response MDL 
CAFLUX 7.2% of max TCDD induction 
15 pg TCDD-EQ glip-1 
(0.05 pmol TCDD-EQ glip-1) 
AREc32 IR 1.38 
1 ng TCDD-EQ glip-1 
(3 pmol TCDD-EQ glip-1) 
p53-bla IR 1.41 0.3 µg mitomycin-EQ glip-1 
NF-κB-bla IR 1.37 60 pg TNFα-EQ glip-1 
 
Section SI-9: Error propagation of EC- and REP-values. 
Error was propagated for EC and REP of each chemical and sample tested and BEQ of 
designed mixtures, passive sampling extracts and original blubber samples using the 
following equations. The standard errors of logEC50 for the CAFLUX assay and of slope for 
the other bioassays were provided in the regression and given to propagate the error for EC, 
REP, BEQ and percentage effect explained. 
 
For CAFLUX, 
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For bioassays based on IR (AREc32, NF-κB and p53) 
σslope
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Table SI-6: Combined concentration-response curves (n=4-8) for individual compounds tested in bioassays. 
Compound AhR Nrf2 p53 NF-κB 
TCDD 
 
   
PeCDD 
 
   
HxCDD 
 
   
HpCDD 
 
   
! !
!
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Compound AhR Nrf2 p53 NF-κB 
OCDD 
 
   
PCB 52 
  
 
 
PCB 101 
 
   
PCB 126 
   
 
! !
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Compound AhR Nrf2 p53 NF-κB 
PCB 169 
 
   
BaP 
 
   
Pyr 
 
 
  
Phe 
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Compound AhR Nrf2 p53 NF-κB 
BDE 47 
 
   
BDE 209 
 
   
p,p'-DDT 
 
 
  
p,p'-DDD 
 
   
! !
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Compound AhR Nrf2 p53 NF-κB 
p,p'-DDE 
    
HCB 
 
 
  
γ-HCH 
 
   
Bifenthrin 
 
   
! !
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Compound AhR Nrf2 p53 NF-κB 
Permethrin 
 
   
B[b]F 
 
   
B[k]F 
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Table SI-7: Combined concentration-response curves (n=3-6) for PDMS passive sampling extracts in bioassays. 
Sample no. AhR Nrf2 p53 NF-κB 
01 
    
02 
    
03 
    
04 
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Sample no. AhR Nrf2 p53 NF-κB 
05 
    
06 
    
07 
    
08 
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Sample no. AhR Nrf2 p53 NF-κB 
09 
    
10 
    
11 
    
12 
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Sample no. AhR Nrf2 p53 NF-κB 
13 
    
14 
    
15 
    
16 
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Sample no. AhR Nrf2 p53 NF-κB 
17 
    
18 
    
19 
    
20 
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Sample no. AhR Nrf2 p53 NF-κB 
21 
    
22 
    
23 
    
24 
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Sample no. AhR Nrf2 p53 NF-κB 
25 
    
26 
    
27 
    
28 
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Sample no. AhR Nrf2 p53 NF-κB 
29 
    
30 
    
31 
    
32 
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Sample no. AhR Nrf2 p53 NF-κB 
33 
    
34 
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Table SI-8: EC and BEQ values of dugong blubber samples (p53 and NFκB not tabulated because all values were <MDL). 
Sample no. 
AhR  Nrf2 (-S9)  Nrf2 (+S9) 
EC50,PDMS 
(gPDMS 
Lbioassay-1) 
BEQbio,PDMS 
(pmol 
TCDD-EQ glip-1) 
BEQbio,sample 
(pmol 
TCDD-EQ glip-1) 
 
ECIR1.5,PDMS 
(gPDMS 
Lbioassay-1) 
BEQbio,PDMS 
(pmol 
TCDD-EQ glip-1) 
BEQbio,sample 
(pmol 
TCDD-EQ glip-1) 
 
ECIR1.5,PDMS 
(gPDMS 
Lbioassay-1) 
BEQbio,PDMS 
(pmol 
TCDD-EQ glip-1) 
BEQbio,sample 
(pmol 
TCDD-EQ glip-1) 
01 >15,000 <0.0016 <0.05  1,318±219 0.30±0.06 9.08±1.81  >2,620 <0.10 <3.1 
02 3,739±543 0.006±0.002 0.19±0.07  900±85 0.44±0.06 13.3±1.92  >2,620 <0.10 <3.1 
03 >15,000 <0.0016 <0.05  491±56 0.81±0.13 24.3±3.8  >2,620 <0.10 <3.1 
04 >15,000 <0.0016 <0.05  813±101 0.49±0.08 14.7±2.4  >2,620 <0.10 <3.1 
05 1,756±401 0.013±0.006 0.41±0.18  1,570±277 0.25±0.05 7.62±1.58  >2,620 <0.10 <3.1 
06 1,233±338 0.019±0.009 0.58±0.28  752±87 0.53±0.08 15.9±2.5  1,202±183 0.48±0.09 14.4±2.7 
07 8,916±516 0.0026±0.0007 0.081±0.020  1,365±124 0.29±0.04 8.76±1.25  >2,620 <0.10 <3.1 
08 996±184 0.024±0.008 0.72±0.23  1,050±143 0.38±0.06 11.4±2.0  >2,620 <0.10 <3.1 
09 >15,000 <0.0016 <0.05  506±64 0.78±0.13 23.6±3.9  >2,620 <0.10 <3.1 
10 >15,000 <0.0016 <0.05  1,488±239 0.27±0.05 8.04±1.56  >2,620 <0.10 <3.1 
11 >15,000 <0.0016 <0.05  >2,620 <0.10 <3.1  >2,620 <0.10 <3.1 
12 >15,000 <0.0016 <0.05  >2,620 <0.10 <3.1  >2,620 <0.10 <3.1 
13 >15,000 <0.0016 <0.05  165±23 2.41±0.42 72.5±12.7  357±51 1.34±0.32 40.1±9.7 
14 4,215±304 0.006±0.001 0.17±0.04  177±30 2.25±0.45 67.5±13.6  284±21 1.67±0.36 50.4±11.0 
15 5,269±295 0.0046±0.0010 0.13±0.02  298±46 1.33±0.25 40.0±7.5  >2,620 <0.10 <3.1 
16 7,478±1,076 0.0032±0.0013 0.096±0.039  380±87 1.04±0.26 31.4±8.0  >2,620 <0.10 <3.1 
17 7,025±1,372 0.0034±0.0018 0.10±0.05  217±24 1.83±0.29 55.1±8.7  >2,620 <0.10 <3.1 
18 2,341±481 0.011±0.005 0.31±0.13  2,493±341 0.16±0.02 4.80±0.84  >2,620 <0.10 <3.1 
19 >15,000 <0.0016 <0.05  334±27 1.19±0.16 35.7±4.8  >2,620 <0.10 <3.1 
20 >15,000 <0.0016 <0.05  >2,620 <0.10 <3.1  >2,620 <0.10 <3.1 
21 14,490±2,293 0.0017±0.0009 0.051±0.027  259±34 1.54±0.27 46.2±7.9  >2,620 <0.10 <3.1 
22 >15,000 <0.0016 <0.05  >2,620 <0.10 <3.1  >2,620 <0.10 <3.1 
23 >15,000 <0.0016 <0.05  >2,620 <0.10 <3.1  >2,620 <0.10 <3.1 
24 >15,000 <0.0016 <0.05  >2,620 <0.10 <3.1  >2,620 <0.10 <3.1 
25 >15,000 <0.0016 <0.05  284±23 1.40±0.19 42.1±5.7  >2,620 <0.10 <3.1 
26 >15,000 <0.0016 <0.05  >2,620 <0.10 <3.1  >2,620 <0.10 <3.1 
27 5,152±920 0.0047±0.0019 0.14±0.05  128±18 3.12±0.56 93.5±17.0  616±78 1.14±0.21 34.4±6.5 
!
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Table SI-8 (continued) 
Sample no. 
AhR  Nrf2 (-S9)  Nrf2 (+S9) 
EC50,PDMS 
(gPDMS 
Lbioassay-1) 
BEQbio,PDMS 
(pmol 
TCDD-EQ glip-1) 
BEQbio,sample 
(pmol 
TCDD-EQ glip-1) 
 
ECIR1.5,PDMS 
(gPDMS 
Lbioassay-1) 
BEQbio,PDMS 
(pmol 
TCDD-EQ glip-1) 
BEQbio,sample 
(pmol 
TCDD-EQ glip-1) 
 
ECIR1.5,PDMS 
(gPDMS 
Lbioassay-1) 
BEQbio,PDMS 
(pmol 
TCDD-EQ glip-1) 
BEQbio,sample 
(pmol 
TCDD-EQ glip-1) 
28 >15,000 <0.0016 <0.05  >2,620 <0.10 <3.1  >2,620 <0.10 <3.1 
29 >15,000 <0.0016 <0.05  >2,620 <0.10 <3.1  >2,620 <0.10 <3.1 
30 >15,000 <0.0016 <0.05  >2,620 <0.10 <3.1  >2,620 <0.10 <3.1 
31 >15,000 <0.0016 <0.05  269±40 1.48±0.27 44.4±8.1  >2,620 <0.10 <3.1 
32 >15,000 <0.0016 <0.05  >2,620 <0.10 <3.1  >2,620 <0.10 <3.1 
33 >15,000 <0.0016 <0.05  144±15 2.77±0.41 83.1±12.5  195±20 2.45±0.90 73.4±27.1 
34 >15,000 <0.0016 <0.05  >2,620 <0.10 <3.1  >2,620 <0.10 <3.1 
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Section SI-10: Do co-extracted lipids interfere with the bioassay response? 
In the current experimental setting for PDMS-blubber partitioning, approximately 1.3 mg 
lipid diffused into one PDMS disk upon equilibrium.1 The combined PDMS passive sampling 
extracts from one dugong blubber sample would contain ~20 mg lipid. It is therefore 
important to address the effect of lipid on tested biological endpoints and decide the amount 
of the extract (hence lipid) diluted and dosed in the bioassay so that observed effect in 
bioassays can presumably be attributed to exogenous chemicals accumulated in the sample. 
As we have demonstrated in our previous study,1 lipids co-extracted from blubber samples 
did not activate AhR, which responds specifically to a narrow range of dioxin-like chemicals. 
Here, we tested potential interference by lipids for Nrf2, p53 and NF-κB using triolein as a 
storage lipid model. Triolein activated Nrf2-mediated oxidative stress response with an 
ECIR1.5 of 0.33±0.06 gtriolein mLbioassay-1 and became more potent when treated with S9 enzyme 
cocktails (ECIR1.5 = 0.18±0.04 gtriolein mLbioassay-1) (Figure SI-5).  
 
Figure SI-5: Concentration-response curves of triolein in the three bioassays (Nrf2 tested 
additionally in the presence of S9 metabolic enzyme cocktail). 
 
To exclude the lipid effect on Nrf2 induction, we only dosed the passive sampling extract in 
one PDMS-equivalent volume. The concentration of triolein equivalent to the maximum 
concentration from the PDMS extract dissolved in the assay medium was lower than its 
ECIR1.5 by an order of magnitude. Triolein did not show any induction effect on p53 and NF-
κB throughout the concentration range tested (Figure SI-5). Therefore, we conclude that the 
lipids co-extracted in the PDMS passive sampling extracts are unlikely to cause a biological 
response. 
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Figure SI-6: Temporal trend of (A) AhR-active chemical burdens and (B) Nrf2-active 
chemical burdens in dugong blubber samples across the years (data points below MDL 
assigned as MDL, which was represented as the dashed line for each corresponding endpoint). 
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Table SI-9: Chemical composition and experimental EC50 of defined mixtures for AhR-mediated activity in the CAFLUX assay. 
Defined mixture no. 
Concentration in sample (pmol glip-1)* BEQchem,iceberg** 
(pmol TCDD-EQ glip-1) 
BEQbio,sample# 
(pmol TCDD-EQ glip-1) 
% effect explained## 
TCDD PeCDD HxCDD HpCDD OCDD 
1 <MDL 0.0158 0.0694 0.0883 0.2372 0.06±0.004 <0.05 - 
2 0.0069 0.0573 0.1398 0.1053 0.1223 0.15±0.006 0.19±0.07 78.9±28.9 
3 0.0003 0.0021 0.0077 0.0937 0.2292 0.019±0.001 <0.05 - 
4 0.0012 0.0149 0.0441 0.0365 0.0390 0.042±0.005 <0.05 - 
5 0.0050 0.0374 0.1940 0.3514 0.9086 0.18±0.05 0.41±0.18 44.2±19.9 
6 0.0264 0.1184 0.2795 0.1189 0.0898 0.30±0.01 0.58±0.28 58.1±28.7 
7 0.0018 0.0162 0.0902 0.2139 0.5294 0.088±0.014 0.081±0.020 108.6±27.1 
8 0.0306 0.2286 0.9532 1.2218 2.0013 0.86±0.27 0.72±0.23 119.4±51.7 
9 0.0022 0.0110 0.0521 0.0760 0.1828 0.047±0.003 <0.05 - 
10 0.0007 0.0080 0.0381 0.0521 0.2118 0.034±0.002 <0.05 - 
*Data from Table SI-4 with conversion from mass-based concentrations into molar-based concentrations. 
**Calculated using equation 5 in the main text; error propagated by equation SI-7. 
#Data from Table SI-8. 
##Error propagated by equation SI-13. 
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Table SI-10: Chemical composition and experimental ECIR1.5 of defined mixtures for Nrf2-mediated oxidative stress response in the AREc32 
assay. 
Defined mixture 
no. 
Total concentration of 
defined mixture 
chemicals* 
(pmol glip-1) 
Molar composition of chemicals in defined mixture (%)** 
ECIR1.5,def mix 
(pM) 
BEQbio,def mix*** 
(pmol  
TCDD-EQ glip-1) 
BEQchem,def mix# 
(pmol  
TCDD-EQ glip-1) 
BEQbio,sample## 
(pmol  
TCDD-EQ glip-1) 
% effect explained### 
TCDD PeCDD HxCDD HpCDD OCDD 
1 0.41 0 3.9 16.9 21.5 57.9 3,169±375 0.052±0.012 0.034±0.005 9.08±1.81 0.57±0.16 
2 0.43 1.6 13.3 32.5 24.5 28.4 1,425±175 0.12±0.02 0.089±0.018 13.3±1.92 0.90±0.17 
3 0.33 0.1 0.6 2.3 28.4 69.5 3,623±318 0.037±0.008 0.013±0.002 24.3±3.8 0.15±0.04 
4 0.14 0.9 10.6 31.5 26.1 27.9 2,942±176 0.016±0.003 0.025±0.003 14.7±2.4 0.17±0.03 
5 1.50 0.3 2.5 12.9 23.4 60.6 3,763±377 0.18±0.04 0.11±0.03 7.62±1.58 2.46±0.69 
6 0.63 4.2 18.8 44.4 18.9 14.3 1,248±119 0.08±0.02 0.18±0.05 15.9±2.5 0.50±0.09 
7 0.85 0.2 1.9 10.6 25.2 62.3 3,209±332 0.10±0.02 0.053±0.011 8.76±1.25 1.22±0.26 
8 4.44 0.7 5.1 21.5 27.5 45.1 3,175±200 0.55±0.17 0.51±0.10 11.4±2.0 4.89±1.11 
9 0.32 0.7 3.4 16.3 23.8 57.1 3,365±401 0.041±0.009 0.028±0.003 23.6±3.9 0.17±0.04 
10 0.31 0.2 2.6 12.3 16.8 68.3 3,942±642 0.039±0.011 0.019±0.002 8.04±1.56 0.48±0.15 
*Sum of individual dioxin congener concentrations from Table SI-4. 
**Calculated as the mixing ratios of PCDDs in the defined mixture using the concentration of each chemical (data from Table SI-4) divided by the total concentration of 
defined mixture chemicals 
***Calculated using equation 6 in the main text with error propagated by equation SI-14. 
#Calculated using equation 5 in the main text with error propagated by equation SI-13. 
##Data from Table SI-8. 
###Error propagated by equation SI-15.  
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Figure SI-7: Comparison between modeled and experimental BEQs values of selected 
defined mixture samples for oxidative stress (data from Table SI-10). 
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Section SI-11: Reduction of bioavailability of chemicals in the presence of S9. 
The protein and lipid content of rat liver S9 fraction is 20 gp LS9-1 
(https://tools.lifetechnologies.com/content/sfs/COAPDFs/2014/RT040A_RTS9PL.pdf), and 
6 glip LS9-1 (no data available on direct measurement of rat liver S9 lipid content; assuming 
microsomal lipid as the major lipid fraction in S9)24, 25 respectively. In the current protocol, 
the added S9 in medium is 1% (V/V), thus introducing additional protein at 0.2 gp Lmedium-1 
and lipid at 0.06 glip Lmedium-1. The original medium concentration of proteins (4.3 gp Lmedium-1) 
and lipid (0.11 glip Lmedium-1) supplemented from 10% fetal bovine serum in the AREc32 
assay (Section SI-4). S9 incorporation thus did not cause a significant change in medium 
protein content (~5%) but may introduce remarkable increase in medium lipid content 
(~50%), which would in theory deplete additional ~20% of the free dissolved fraction of the 
hydrophobic chemicals tested chemicals (equations SI-26 and SI-27 adapted from the mass 
balance model by Liu et al.26). 
medium
protein
BSAw
medium
lip
lipw
w
V
m
K
V
m
K1
1f
++
=                                       (SI-26)         
100%
f
ff
f in change %
w,-S9
S9w,w,-S9
w ⋅
−
= +                                       (SI-27)                                                                     
Where fw represents the freely dissolved (or bioavailable) fraction of a chemical in medium 
water; Klipw and KBSAw represent liposome- and bovine serum albumin (BSA)-water partition 
coefficients of chemicals (Table SI-2); mlip/Vmedium and mprotein/Vmedium represent medium 
concentrations of lipid and protein, respectively (assuming negligible amount of lipid and 
proteins in cells). 
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Chapter V. Coupling Passive Sampling with In Vitro Bioassays 
and Chemical Analysis to Understand Combined Effects of 
Bioaccumulative Chemicals in Blood of Marine Turtles 
 
Reprinted with permission from: Jin, L., Escher, B.I., Limpus, C.J., and Gaus, C. 2015. 
Coupling passive sampling with in vitro bioassays and chemical analysis to understand 
combined effects of bioaccumulative chemicals in blood of marine turtles. Chemosphere 138, 
292–299. Copyright (2015) Elsevier. 
 
This chapter describes the proof of concept of adapting the passive sampling technique 
developed in Chapter III to achieve enrichment of bioaccumulative chemicals from turtle 
blood, and to understand the toxic potential of these chemical mixtures. Using a range of 
model hydrophobic chemicals, a depletive PDMS-blood partitioning system was 
quantitatively designed and experimentally validated for equilibration time, PDMS-blood 
partition coefficients and mass transfer. The validated method was coupled with in vitro 
bioassays to understand the contribution of select POPs to the overall toxicologically relevant 
chemical burdens in blood samples of green turtles. 
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Supplemental Material 
Coupling passive sampling with in vitro bioassays and chemical 
analysis to understand combined effects of bioaccumulative chemicals 
in blood of marine turtles 
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Figure S4: Correlation between body condition index and BEQbio,blood for A) AhR-mediated 
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Section S1. Theoretical considerations of KPDMS-blood 
While it can be empirically determined as the ratio of the equilibrium concentration of a 
chemical (i) in PDMS (CPDMS,i) and that in blood (Cblood,i), KPDMS-blood can also be derived 
from the ratio between PDMS-water (KPDMSw) and blood-water (Kbloodw) partition coefficients. 
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For blood, lipid, protein and water are the three major compartments relevant to partitioning 
of chemicals (Escher et al., 2011). Kbloodw is the summation of partition coefficients between 
these compartments and water, adjusted to their respective fraction in blood. 
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Where Vw/Vblood (≈1), mlip/Vblood and mp/Vblood are the volume or mass fractions of water, 
lipid and protein in blood, respectively; and Klipw and Kpw represent the lipid- and protein-
water partition coefficients, respectively. 
 
For chemicals considered relevant for bioaccumulation (logKlipw>2), mlip/VbloodKlipw + 
mp/VbloodKpw >>1, and equations (1) and (2) can be combined to provide the KPDMS-blood: 
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Our previous quantitative structure-activity relationship analysis and experimental work (Jin 
et al., 2013) demonstrated that Klipw and KPDMSw are both proportional to Kow with a 
theoretical ratio of Klipw to KPDMSw of 10 for chemicals across a wide range of 
physicochemical properties. This ratio (or Klip-PDMS) was empirically determined to be 30 (Jin 
et al., 2013), which was used in equation 3. Here, we derived the theoretical value of Kp-PDMS 
using quantitative structure-activity relationships. 
 
Literature data of Kpw (deBruyn and Gobas, 2007; Endo and Goss, 2011; Escher et al., 2011; 
Endo et al., 2013) were compiled for linear regression analyses against Kow. We only used 
those Kpw values determined with a model serum albumin (bovine serum albumin), which is 
the most abundant and representative protein type in animal/human blood, and excluded 
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those determined with structural proteins. Therefore the term Kpw in this study is equivalent 
to bovine serum albumin-water partition coefficients (KBSAw) in the literature. For regression 
analyses, chemicals with logKow lower than 2 were excluded because they have low 
bioaccumulation potential. The slope of the regression line was fixed at 1. Here we also 
included the previously established linear regression curves and equations of Klipw and 
KPDMSw against Kow (Jin et al., 2013) for comparison (Figure S1A). The regression equations 
showed that Kpw is in general 1:20 in relation to Kow, which compares to the relationship 
between KPDMSw and Kow (1:10), and between Klipw and Kow (1:1) (Figure S1B). While we 
noticed larger residual errors for the logKpw-logKow regression compared to the other two 
regressions due to more scattered data plots, they are acceptable for a conceptual 
understanding on the quantitative partitioning between phases. The difference in intercept 
between the parallel logKPDMSw-logKow and logKpw-logKow lines represents the theoretical 
value of logKp-PDMS (-0.3, thus Kp-PDMS ~0.5) (Figure S1B). 
 
Figure S1: A) logKlipw (blue diamands), logKPDMSw (black triangles) and logKpw (orange 
circles) in relation to logKow indicative of hydrophobicity; B) Conceptual figure showing the 
theoretical relationship between logKlipw and logKow (1:1 blue dashed line), between 
logKPDMSw and logKow (1:10 black dashed line) and between logKpw and logKow (1:20 orange 
dashed line). 
!
With mlip/Vblood and mp/Vblood being constant for a given blood sample, KPDMS-blood is expected 
to be constant across a wide range of chemicals with diverse physicochemical properties. 
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Based on KPDMS-blood, we can then determine the experimental blood/PDMS volume ratio 
(Vblood/mPDMS) that would achieve the desired exhaustive depletion of chemicals in blood. 
Assuming negligible sorption to the glass vial wall, the fraction of a chemical extracted by 
PDMS (fPDMS,i) can be estimated: 
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blood
bloodPDMS
bloodiblood,PDMSiPDMS,
PDMSiPDMS,
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iPDMS,
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−
+
=
+
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+
=          (S4) 
Where mPDMS,i and mblood,i represent the mass of a chemical extracted by PDMS and 
remaining in blood suspension, respectively.
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Table S1: Biometric information on the 15 green turtle samples used in the study. 
Sample 
no. Sex Age 
Curved carapace length 
(CCL; cm) 
Body weight 
(BW; kg) 
Body condition index* 
(lg[BW] / lg[CCL]) 
Health condition**  
(visual categorization) 
#1 Male Juvenile 44.6 10.1 1.64 very poor 
#2 Female Juvenile 48.0 8.6 1.80 very poor 
#3 Male Juvenile 46.8 8.7 1.78 poor 
#4 Male Juvenile 44.2 8.0 1.82 good 
#5 Indefinite Juvenile 47.2 9.3 1.72 very poor 
#6 Female Juvenile 60.2 21.5 1.33 poor 
#7 Male Juvenile 62.0 25.0 1.28 good 
#8 Female Juvenile 51.7 14.6 1.47 poor 
#9 Female Juvenile 52.4 15.4 1.45 good 
#10 Indefinite Juvenile 46.6 8.8 1.77 good 
#11 Male Juvenile 44.4 9.7 1.67 very poor 
#12 Indefinite Juvenile 45.3 8.8 1.75 good 
#13 Female Juvenile 47.6 8.8 1.78 very poor 
#14 Male Juvenile 47.4 10.2 1.66 poor 
#15 Male Juvenile 52.8 14.8 1.47 good 
*Equation according to Flint et al. (2014) 
**Health condition scores from Flint et al. (2014)
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Section S2: Additional information on the procedure to determine lipid and protein 
content in lipid. 
Blood lipid was solvent extracted and gravimetrically determined using the Bligh and Dyer 
method (Bligh and Dyer, 1959) modified by Smedes (1999) as follows: 0.8 mL of 2-propanol, 
1 mL of cyclohexane, and 0.1 mL of Milli-Q water were added to 1 mL of turtle blood in a 
test tube. The mixture was vortexed for 30 s and then sonicated for 5 min. After 
centrifugation at 2000 rpm for 5 min, the upper layer (cyclohexane) was collected. The 
extraction process was repeated. The combined cyclohexane extracts were blown to dryness 
under a gentle stream of nitrogen, and further dried over silica gel in a vacuum desiccator. 
Lipid content was determined gravimetrically. A liposome suspension (1 mL 10 glip L-1) 
served as the positive control. Liposomes were prepared with 1-palmitoyl-oleyl-
phosphatidylcholine (POPC) following a previously established procedure (Kaiser and 
Escher, 2006). The results of blood lipid content were corrected for the recovery of POPC, 
which was 80.6±5.8% (n=2). BSA (1 mL 40 gBSA L-1) was used as the negative control. Only 
0.12±0.15% (n=3) of BSA weight was extracted from the negative controls, suggesting that 
the extraction method excludes protein coextraction. 
 
Blood protein content was colorimetrically determined using the Lowry method (Lowry et al., 
1951) adapted to 96 well plates. The Lowry reagent was prepared by mixing three solutions 
of NaOH (0.2 M), sodium dodecyl sulfate (SDS; 7 µM) and copper reagent (1 M Na2CO3, 50 
µM CuSO4·5H2O and 20 µM potassium sodium tartrate). In each well, 20 µL BSA standard 
or a sample were added, followed by 200 µL of Lowry reagent. The linear dilution series of 
BSA standard ranged from 0.15-0.9 mg mL-1. Turtle blood samples were diluted with Milli-Q 
water in such a way that the expected concentration would fall within the standard calibration 
range. After the plate was shaken on a vortex for 5 min, 20 µL of Folin-Ciocalteu’s phenol 
reagent (2 M) was then added to each well. The plate was shaken again for 30 min to ensure 
that reactions took place, and then read for absorbance at 750 nm using with the FLUOstar 
Omega plate reader (BMG Labtech). The protein content in each sample was then calculated 
from the BSA standard calibration curve. 
 
The lipid content in green turtle blood samples measured in this study fell within the range of, 
but was on average lower than, that determined previously for samples collected from 
Southeast Queensland (Table S2). This is consistent with the observation that green turtles 
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were emaciated during the flood event (Flint et al., 2014). The measured protein content fell 
well within the range of previously reported values (Table S2) . 
 
Table S2: Lipid and protein content in green turtle blood samples. 
Sample no. lipid content  (glip Lblood-1) 
protein content  
(gp Lblood-1) 
Predicted KPDMS-blood** 
(Lblood kgPDMS-1) 
Literature data 
#0* 0.98±0.09 39.6±4.7 20 
Lipid content (glip Lblood-1) 
0.6-4.6 (Arthur et al., 2008) 
 
 
Protein content (gp Lblood-1) 
29-45 (Moon et al., 1999) 
20-61 (Whiting et al., 2007) 
21-62 (Flint et al., 2010) 
#1 1.2 39.2 18 
#2 1.4 38.4 16 
#3 1.2 33.1 19 
#4 1.0 32.0 22 
#5 1.5 36.5 16 
#6 1.3 37.4 17 
#7 1.0 39.3 20 
#8 1.1 36.7 19 
#9 0.9 42.1 21 
#10 1.3 39.8 17 
#11 1.1 36.8 19 
#12 1.2 35.4 19 
#13 1.4 33.7 17 
#14 0.8 38.9 23 
#15 1.1 41.5 19 
*Sample #0 was used for time series investigations in the method validation phase while the other samples for method 
application; Except for sample #0 with triplicate determinations for lipid and protein content, all the other samples only had 
one determination due to the limited sample size. **Calculated using equation S3. 
 
Section S3: Additional information on uptake of blood matrices into PDMS. 
To measure the uptake of blood matrices into PDMS disks, we used a microbalance (accurate 
to 0.001 mg) to monitor the weight change of four PDMS disks exposed to 5 mL of blood 
(Table S3). To ensure there is no residue remaining on the PDMS surface, PDMS disks were 
thoroughly rinsed with Milli-Q water and wiped with lint-free tissue. The four disks gained 
an average of 0.12 mg after partitioning with turtle blood. Such an amount of matrix uptake is 
far lower than the 1.3 mg per PDMS disk we found in our previous PDMS-blubber 
partitioning experiments (Jin et al., 2013). 
 
Table S3: Weight (mg) change of PDMS pre- and post-partitioning with blood. 
 
Replicate 1 Replicate 2 Replicate 3 
four PDMS disks pre-partitioning 942.09 943.52 940.71 
four PDMS disk post-partitioning 942.22 943.62 940.85 
Net weight gain 0.13 0.10 0.14 
% weight gain 0.014 0.011 0.015 
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Proteins or nucleotides can be excluded as the major matrix because charged molecules 
would not diffuse into PDMS. Assuming all the matrix taken up by PDMS was lipid, we 
estimated the deviation of the true KPDMS-blood (KPDMS-blood,true) from the measured KPDMS-blood 
(KPDMS-blood,measured; geometric mean of 14 Lblood kgPDMS-1) using equation (S5). KPDMS-
blood,measured was higher than KPDMS-blood,true by only 0.5% in the present study. 
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Where Klip-PDMS,true represents the true lipid-PDMS partition coefficient and is a constant of 
37 kgPDMS kglip-1 (Jin et al., 2015); mlip in PDMS/mPDMS represents the mass concentration of 
lipid that diffused into PDMS and is 0.013% (kglip kgPDMS-1) on average. 
 
With regards to the matrix effect on bioassays, if the matrix were all lipid, the amount of lipid 
would be unlikely to trigger a significant biological response itself (Jin et al., 2015) or to 
cause kinetics-related interference with true biological response (Jin et al., 2013) in the assays 
used. If the matrix were all carbohydrates, dosing of passive sampling extracts would 
introduce a maximum of 0.5 g L-1 of carbohydrates into the medium, which is minor 
compared to the original medium concentration (e.g., 4.5 g L-1 in the AREc32 assay medium).  
 
Additionally, carbohydrates have negligible sorptive capacity for bioaccumulative chemicals. 
Therefore, we can conclude that the blood matrix co-extracted by PDMS would not cause 
artefacts in the assays used. 
 
Section S4: Additional information on estimation of equilibration time, KPDMS-blood and 
mass transfer. 
To assess the time to equilibrium, the ratio of the concentration of a PCDD congener in 
PDMS to that in blood was plotted against the exposure time (Figure 1 in the main text). For 
chemicals where equilibrium had been established, a first order kinetic model was fitted to 
the data according to equation S6. 
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Figure S2: Time series of PCDD uptake into PDMS (TCDD shown in Figure 1 in the main 
text as an example). 
 
The equilibrium KPDMS-blood and the rate constant k were derived from the curve regression. 
The time to reach 95% of the equilibrium KPDMS-blood (t95) was calculated as the estimated 
equilibration time.  
k
ln(0.05)t 95 −
=                                                       (S7) 
The estimated equilibration time (t95), KPDMS-blood, and corresponding mass transfer (fPDMS) for 
the test chemicals are given in Table S4.  
 
To compare the modeled and measured KPDMS-blood, we established an alternative means to 
estimate KPDMS-blood. In the main text, the theoretical value of 20 Lblood kgPDMS-1 is based on 
universal Kpw-KPDMSw (1:2) and Klipw-KPDMSw (1:30) relationships using equation 3. Empirical 
determinations of KPDMSw (DiFilippo and Eganhouse, 2010), Klipw (Endo et al., 2011) and Kpw 
(Endo and Goss, 2011) are also available in the literature for some of the test chemicals. 
Experimentally determined data for all three partition cofficients were only found for the test 
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PBDE congeners. These values offer to cross check the deviation from theoretical calculation 
in comparison with measured KPDMS-blood (Table S4). 
 
The calculated KPDMS-blood values for PBDEs based on the empirically determined Klipw, Kpw 
and KPDMSw were higher than the directly measured KPDMS-blood (by a factor of 3-9), as well as 
the theoretical value of 20 (by a factor of 2-4) (based on the constant Kpw/KPDMSw of 0.5 and 
Klipw/KPDMSw of 30). The empirical ratios of Kpw/KPDMSw for the PBDE congeners ranged 
from 0.24-0.56, which are close to the modeled constant of 0.5. The theoretical ratios of 
Klipw/KPDMSw calculated from experimentally determined Klipw and KPDMSw for the PBDE 
congeners ranged from 3.2-6.6, which deviated greatly from the empirical value of 30 and 
caused discrepancies between the calculated KPDMS-blood and theoretical and measured ones. In 
a recent study (Allan et al., 2013), lipid-PDMS partition coefficients (Klip-PDMS) for BDE28 
(4.6), BDE47 (27.2), BDE100 (38.7) and BDE99 (53.5) were experimentally determined in 
fish.  Klip-PDMS is in principle equal to Klipw/KPDMSw. However, except for BDE28 with 
measured Klip-PDMS closer to the theoretical value of Klipw/KPDMSw (3.2), all the other 
congeners had Klip-PDMS closer to the empirical value of 30. Thus, caution needs to be taken 
when estimating Klip-PDMS directly from Klipw and KPDMSw in complex matrices. 
!
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Table S4: Measured KPDMS-blood and corresponding mass transfer of the test chemicals in comparison with estimated values. 
Compound t95 (h) 
Measured KPDMS-blood 
(L kg-1) (95% CI) 
fPDMS,i (%) 
(95% CI) log Kow
* 
Measured 
log Klipw 
(L kg-1)** 
Measured 
log Kpw 
(L kg-1)*** 
Measured  
log KPDMSw 
(L kg-1)# 
Calculated KPDMS-blood 
(L kg-1)## 
TCDD 42.6 21.4 (19.6-23.2) 81.4 (75.7-87.0) 6.67 6.90 n.a. 5.59 - 
PeCDD 51.4 22.1 (20.1-23.9) 82.0 (78.0-85.9) 7.08 7.07 n.a. 5.71 - 
HxCDD 62.3 18.9 (17.2-20.5) 78.3 (76.2-80.3) 7.56 7.15 n.a. 5.89 - 
HpCDD 76.6 15.0 (12.4-17.5) 73.3 (71.3-75.2) 7.83 7.01 n.a. n.a. - 
OCDD 90.2 10.4 (7.6-13.3) 64.0 (61.4-66.5) 8.32 7.33 n.a. n.a. - 
PCB 28  - 16.2 (13.6-18.7) 75.8 (73.7-77.8) 5.71 n.a. n.a. 5.27 - 
PCB 52  - 20.3 (17.3-23.2) 79.1 (74.8-83.3) 5.79 5.88 n.a. 5.49 - 
PCB 101  - 29.1 (24.0-34.1) 84.2 (81.7-86.6) 6.41 n.a. n.a. 6.07 - 
PCB 118  - 12.6 (11.5-13.6) 70.7 (67.6-73.7) 6.57 n.a. n.a. 6.09 - 
PCB 138  - 16.5 (13.5-19.4) 76.0 (73.2-78.7) 6.83 n.a. n.a. 6.30 - 
PCB 153  - 12.9 (10.5-15.2) 70.6 (63.9-77.2) 6.92 n.a. n.a. 6.46 - 
PCB 180  - 10.6 (9.0-12.1) 67.0 (64.2-69.7) 7.21 6.33 n.a. 6.74 - 
BDE 28 - 12.4 (10.9-14.8) 70.4 (67.5-73.2) 5.94 6.21 5.12 5.70 73.5 
BDE 47 - 9.0 (8.6-9.3) 63.5 (62.8-64.1) 6.81 6.95 5.81 6.13 39.3 
BDE 99 - 9.1 (7.3-10.8) 63.4 (59.0-67.7) 7.32 7.10 5.91 6.53 76.1 
BDE 100 - 10.3 (9.9-10.6) 66.8 (66.2-67.3) 7.24 7.21 6.18 6.43 35.5 
BDE 153 - 8.9 (8.6-9.1) 63.3 (61.7-64.8) 8.37 7.62 6.46 6.80 40.7 
BDE 154 - 8.4 (8.0-8.7) 61.9 (60.2-63.5) 7.82 7.52 6.29 6.90 72.4 
*Data from EPI suite (USEPA, 2008). 
**Data from Endo et al. (2011); n.a. = not available. 
***Data from Endo and Goss (2011). 
#Data from DiFilippo and Eganhouse (2010) and Endo et al. (2011). 
##Calculated using equation S3 based on the empirically determined partition coefficients provided in this table instead of the constant Klip-PDMS and Kp-PDMS.
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Table S5: Derivation of BEQchem of mixtures of identified chemicals in each green turtle blood sample. 
Compound REP
* 
(AhR) 
REP* 
(Nrf2) 
Concentration (pg glip-1) of PCDD/Fs and dioxin-like PCBs measured by exhaustive solvent extraction using HRGC-HRMS  
(data from Gaus!et!al.!(2012))  
#1 #2 #3 #4 #5 #6 #7 #8 #9 #10 #11 #12 #13 #14 #15 
TCDF 0.10 0.10 <5.5 <2.6 3.7 6.1 3.7 21 12 13 43 14 4.4 2.1 <1.2 <2.3 5.2 
PeCDF 0.20 0.20 <3.1 <1.5 <0.71 <0.44 <0.68 6.7 2.4 <0.93 9.0 4.5 7.8 2.0 <1.2 <1.7 <1.7 
HxCDF 0.050 0.050 6.3 <1.3 <1.4 2.1 1.1 9.7 4.0 <1.4 <2.7 2.7 18 3.5 <1.6 <5.6 <3.2 
HpCDF 0.018 0.018 7.6 8.2 8.8 5.6 2.5 4.9 2.9 6.5 4.3 3.7 22 5.9 4.2 9.3 12 
OCDF 0.000077 0.000077 45 55 68 25 25 37 37 36 57 27 42 31 27 60 62 
TCDD 1.0 1.0 <4.4 <4.0 <1.2 <0.74 <0.97 <2.8 <0.99 <1.8 <2.8 <0.69 <2.1 <0.86 <1.5 <4.3 <2.5 
PeCDD 1.1 0.8 <5.0 <2.6 2.7 4.5 <0.89 8.9 7.4 5.0 <3.3 1.9 <2.1 2.8 <1.4 9.2 7.5 
HxCDD 0.30 0.20 9.3 <3.6 7.6 10 7.5 18 51 27 32 5.5 11 6.8 9.8 54 24 
HpCDD 0.090 0.090 36 30 32 21 24 53 50 38 44 18 39 23 34 79 69 
OCDD 0.0020 inactive 150 100 140 58 130 150 200 140 350 75 110 85 120 270 243 
PCB 81 0.00030 0.00030 <54 <55 <33 <25 <49 <65 <35 <71 <57 <44 <47 <31 <51 <78 <65 
PCB 105 0.000042 0.000042 3,300 <660 <390 <300 <360 <780 460 <510 440 <420 810 <380 <610 <940 <780 
PCB 114 0.00034 0.00034 <220 <220 <130 <100 <120 <260 <140 <170 <130 <140 <190 <130 <200 <310 <260 
PCB 118 0.000020 0.000020 11,000 <3,300 <2,000 <1,500 <1,800 <3,900 <2,100 <2,600 <2,000 <2,100 2,900 <1,900 <3,100 <4,700 <3,900 
PCB 123 0.000044 0.000044 390 <220 <130 <100 <120 <260 <140 < 170 <130 <140 440 <130 <200 <310 <260 
PCB 126 0.013 0.017 <110 <110 <65 <50 <60 <130 <69 <86 <67 <69 <94 <63 <100 <160 <130 
PCB 156 0.000055 0.000055 2,000 <660 <390 <300 <360 <780 <410 <510 <403 <420 1,000 <380 <610 <940 <780 
PCB 157 0.0011 0.0011 1,300 <330 <200 <150 <180 <390 <210 <260 <201 <210 400 <190 <310 <470 <390 
PCB 167 0.000030 0.000030 1,800 <440 <260 250 290 <520 <280 <340 <270 <280 1,400 430 500 800 <520 
PCB 169 0.0020 0.0020 <160 <165 <97 <75 <90 <200 <100 <130 <100 <100 <140 <94 <150 <230 <200 
PCB 189 0.000055 0.000055 440 <220 <130 <100 <120 <260 <140 <170 <130 <140 200 <130 <200 <310 <260 
BEQchem,def mix for AhR (pg TCDD-
EQ glip-1)
 8.7 3.0 8.9 11 5.1 24 30 19 20 7.9 11 8.2 6.3 34 22 
BEQchem,def mix for Nrf2 (pg TCDD-
EQ glip-1)
 7.4 2.8 7.1 8.3 4.1 20 23 14 17 6.6 9.6 6.4 5.1 25 18 
*REP values for AhR and Nrf2 of PCDDs, PCB 126 and 169 previously determined in the same bioassays (Jin et al., 2015); REP values for AhR of the other chemicals from those determined in 
similar in vitro systems (Van den Berg et al., 2006); REP values for Nrf2 of the other chemicals modeled using the EC50 (AhR-CAFLUX)-ECIR1.5 (Nrf2-AREc32) relationship of 1:10 previously 
established for persistent dioxin-like chemicals (Jin et al., 2015), which means REP values for Nrf2 in the AREc32 assay are theoretically the same as those for AhR in the CAFLUX assay. 
#Calculated using equation 9 in the main text.
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Table S6: Combined concentration-response curves of PDMS passive sampling extracts of 
turtle blood samples (n=3-4). 
Sample no. AhR Nrf2 
#1 
  
#2 
  
#3 
  
#4 
  
#5 
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#6 
  
#7 
  
#8 
  
#9 
  
#10 
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#11 
  
#12 
  
#13 
  
#14 
  
#15 
  
!
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Table S7: Derivation of BEQbio,blood for green turtle blood samples. 
Sample no. 
AhR  Nrf2 
EC50,PDMS* 
(gPDMS Lbioassay-1) 
BEQbio,PDMS** 
(pg TCDD-EQ gPDMS-1) 
BEQbio,blood# 
(pg TCDD-EQ glip-1) 
 ECIR1.5,PDMS
* 
(gPDMS Lbioassay-1) 
BEQbio,PDMS** 
(pg TCDD-EQ gPDMS-1)  
BEQbio,blood# 
(pg TCDD-EQ glip-1) 
#1 >5,500 <0.20 <12  280±20 460±33 28,000±2,000 
#2 >5,500 <0.20 <12  560±48 230±20 15,000±1,300 
#3 >5,500 <0.20 <12  >1,800 <70 <4,000 
#4 >5,500 <0.20 <12  860±83 150±14 11,000±1,000 
#5 >5,500 <0.20 <12  >1,800 <70 <4,000 
#6 2,400±130 0.45±0.034 25±1.8  380±35 340±30 24,000±2,200 
#7 2,100±140 0.52±0.045 37±3.2  >1,800 <70 <4,000 
#8 2,300±120 0.46±0.033 28±1.9  >1,800 <70 <4,000 
#9 3,500±280 0.31±0.030 25±2.4  930±91 140±13 11,000±240 
#10 >5,500 <0.20 <12  1,400±230 93±15 7,400±1,300 
#11 4,500±390 0.24±0.025 18±1.6  860±100 150±17 7,600±890 
#12 >5,500 <0.20 <12  >1,800 <70 <4,000 
#13 >5,500 <0.20 <12  >1,800 <70 <4,000 
#14 2,600±150 0.41±0.033 37±2.9  740±44 170±10 16,000±930 
#15 3,000±370 0.36±0.048 24±3.1  1,600±210 80±10 5,200±670 
*Derived from concentration-response curves in Table S5. 
**Calculated using equation 6 in the main text. 
#Calculated using equations 8 and 9 in the main text. 
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Figure S3: A) AhR-active and B) Nrf2-active chemical burdens in green turtles of different health 
status. BEQs below the method detection limit (MDL) were assigned as half MDLs. 
 
 
Figure S4: Correlation between body condition index and BEQbio,blood for A) AhR-mediated activity 
or B) Nrf2-mediated oxidative stress response. BEQs below the method detection limit (MDL) were 
assigned as half MDLs. 
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Chapter VI. Concluding Remarks and Outlook 
 
With a synthesis of recent advances in passive sampling, in vitro toxicity screening and mixture 
toxicity concepts, this thesis zooms in on a local environmental issue of chemical pollutants in 
dugongs and green sea turtles in Australia, while delivering globally applicable, new 
methodological approaches to addressing chemical mixture effect in wildlife. 
 
Using typical types of biological samples (dugong blubber and turtle blood), this thesis 
demonstrates the relative advantages of PDMS-based passive sampling in extracting mixtures of 
bioaccumulative chemicals for effect screening. First, this technique offers a non-selective coverage 
of neutral organic chemicals, including both persistent and non-persistent ones. The latter are often 
lost during typical matrix removal steps (e.g., acid treatment) involved in conventional extraction 
methods. Second, polymer-based passive sampling can be practiced in either non-depletive or 
depletive manner, depending on the purpose. With regards to bioanalytical and chemical assessment 
of biological samples, it would be ideal to extract chemicals in a depletive or better exhaustive way. 
The relative advantage of the depletive PDMS approach is that PDMS can offer phase separation 
(e.g., proteins excluded from PDMS extraction and minimal lipid taken up by PDMS), thus saving 
the active labour involved in conventional approaches to remove these matrices. Third, the 
circumvents the logistic needs in transporting biological samples from the field, which are all 
common limitations encountered in conventional wet chemistry procedures. Chemical sampling 
may be easily performed in situ where veterinarians conduct necropsy on stranded animals or 
during blood sampling in live animals. 
 
While the PDMS-based method opens opportunities for environmental applications, there are still 
limitations with the method that need to be overcome. For lipid-rich tissue, the lower mass transfer 
renders PDMS incapable of simultaneous exposure and effect assessment. Particularly for chemical 
analysis, increasing amount of PDMS would result in higher lipid transfer into PDMS, thus 
requiring the same extensive clean-up efforts as required for conventional solvent extraction. This 
would fully negate the advantage of the PDMS approach. In this sense, conventional solvent 
extraction with a higher sensitivity for chemical analysis can be complementary to the PDMS 
approach that is more favourable in bioanalytical screening of mixture effects. To promote the 
practical utility of the polymer-based approach, issues such as sampling kinetics, transfer efficiency 
and matrix uptake need to be more systematically evaluated for PDMS as well as other existing 
polymers. Developing new polymers by, for example, surface modification of existing polymers 
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would also be of interest to meet these ends. An optimised polymer-based passive sampling, i.e., 
higher mass transfer and faster sampling kinetics, would enhance our capability of unbiased 
chemical extraction for non-target analytical and bioanalytical screening.  
 
For blood samples, the principal limitations lie in the sample volume that can be ethically obtained. 
Given a small volume of blood commonly collected from an individual animal, neither the PDMS 
approach nor the conventional solvent extraction can offer comprehensive chemical and 
bioanalytical assessment to be performed simultaneously. A pooling strategy for individual samples 
would thus be useful to increase the method sensitivity for a broader-spectrum analysis of both 
bioanalytical endpoints and chemicals. 
 
The test battery of in vitro reporter gene assays coupled with passive sampling allows quantitative 
assessment of chemical burdens and their toxicological relevance for a greater sample throughput. 
The model bioassays used in the thesis, demonstrates the value of these toxicity pathway-based 
assays indicative of some early molecular warning events as lower tier screening tools to evaluate 
the toxicological/biological relevance of the entire chemical burden. With the aid of the BEQ 
concept, this thesis demonstrates that dugongs and green sea turtles along the Queensland coast are 
exposed to a dynamic range of chemical burdens active on AhR signalling (dioxin-like activity) and 
Nrf2-mediated oxidative stress response. Although AhR ligands, including dioxins, dioxin-like 
PCBs and PAHs, are at the same time potent activators of the oxidative stress response pathway, 
they typically explain <5% of the oxidative stress triggered by the samples, while accounting for the 
entire AhR-mediated activity. 
 
To quantitatively link chemical exposure to mixture effect, non-target chemical analysis would be 
required to match the nontarget nature of bioanalytical screening that reveal the overall 
toxicologically relevant chemical burdens. This goal can be achieved by recent advances in 
bioassay-guided sample fractionation techniques and hyphenated instrumental techniques coupled 
with library-based identification tools for unknown chemicals. Meanwhile, the BEQ concept used 
throughout the thesis provides a means to quantitatively interpret the overall biologically active 
burdens in the complex sample mixtures, especially in the case where only a small fraction of the 
mixture effect in wildlife samples could be explained by identified chemicals. All these tools and 
approaches would enhance our power to quantify and prioritise the chemical components 
contributing, for example, to the largely unexplained oxidative stress response from dugong and 
green turtle samples. Moreover, future development of effect-based trigger values would facilitate 
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the quantitative benchmarking of the mixture effect burdens in marine wildlife samples for a more 
informed risk assessment of these chemical mixtures. 
 
Based on the key toxicological findings in this thesis, additional functionally important endpoints of 
higher relevance to population health, such as immunosuppression, endocrine disruption and 
neurological dysfunction, can be added to the existing test battery to further evaluate the later 
manifestation of apical effects. A comprehensive test battery of bioassays can be purpose-tailored 
for event-driven investigations (e.g., oil spills, disease outbreaks, mass mortality events). While all 
the assays used in this thesis were based on mammalian cell models (e.g., human, rat), 
dugong/turtle-specific functional assays can be further developed to incorporate species 
susceptibility into the assay battery. Together with in silico quantitative pathway prediction models, 
these tools would help address species-specific questions regarding exposure and effect in a certain 
dugong/turtle population.  
 
Overall, the approaches developed in this thesis provide a methodological framework for integrated 
exposure and effect assessment. The approach adopted in the proposed study can be extended to 
other wildlife species beyond dugongs and turtles studied in this thesis, thus helping address similar 
research needs globally. These tools can join other toxicological and epidemiological approaches to 
initiate more strategic sampling of marine wildlife samples for hypothesis-driven investigations for 
specific wildlife population. With a mechanistic and quantitative understanding of exposure and 
effect of POPs, we may take a step further toward establishing the role of POPs in the total 
environmental threats to marine wildlife. Such information will help prioritise limited resources in 
management strategies for wildlife conservation.  
